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ABSTRACT 
 
 
 
The tight interplay between endoplasmic reticulum (ER) and mitochondria is a key determinant of 
cell function and survival through the control of intracellular calcium (Ca
2+
) signalling. The 
physical platform for the association between the ER and mitochondria is a domain of the ER called 
the “mitochondria-associated membranes” (MAMs). MAMs are crucial for highly efficient 
transmission of Ca
2+
 from the ER to mitochondria, thus controlling fundamental processes involved 
in energy production and also determining cell fate by triggering or preventing apoptosis. 
In particular, we show that: i) despite different roles in cell survival, all three isoforms of the outer 
mitochondrial membrane protein voltage-dependent anion channels (VDAC) are equivalent in 
allowing mitochondrial Ca
2+
 loading upon agonist stimulation, vice versa VDAC1, by selectively 
interacting with the inositol trisphosphate receptors (IP3Rs) - an interaction that is further 
strengthened by apoptotic stimuli - is preferentially involved in the transmission of the low-
amplitude apoptotic Ca
2+
 signals to mitochondria, highlighting a non-redundant molecular route for 
transferring Ca
2+
 signals to mitochondria in apoptosis; ii) the promyelocytic leukemia (PML) tumor 
suppressor exerts its extranuclear proapoptotic action by its unexpected and fundamental role at 
MAMs, where PML was found in protein complexes with the type 3 IP3R, the protein kinase Akt 
and the phosphatase PP2a, which are essential for Akt- and PP2a-dependent modulation of IP3R 
phosphorylation and in turn for IP3R-mediated Ca
2+
 release from ER; iii) the PTEN (phosphatase 
and tensin homolog deleted on chromosome 10) tumor suppressor localizes at the ER and MAMs, 
and ER-localized PTEN is specifically involved in increasing both Ca
2+
 transfer from the ER to 
mitochondria and cell sensitivity to Ca
2+
-mediated apoptosis. 
The improved knowledge of the functioning of proteins involved in regulating Ca
2+
 signalling may 
reveal novel unexplored pharmacological targets, and help in treating cancer as well as other 
pathologies. 
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ABSTRACT (Italiano): 
 
 
 
L‟accoppiamento funzionale tra reticolo endoplasmatico (ER) e mitocondri è un fattore determinate 
per la funzionalità e la sopravvivenza cellulare, in quanto determina il controllo del segale calcio 
(Ca
2+
) intracellulare. Dal punto di vista fisico, la base per l‟associazione tra ER e mitocondri risiede 
in un dominio dell‟ER definito “membrane associate ai mitocondri” (MAMs). Le MAMs sono 
fondamentali per una trasmissione altamente efficiente degli ioni Ca
2+
 dall‟ER ai mitocondri, e per 
questo controllano processi indispensabili coinvolti nella produzione di energia, ed inoltre 
determinano il destino della cellula facilitando o ostacolando l‟apoptosi. 
Specificamente, abbiamo dimostrato che: i) nonostante svolgano diversi ruoli nella sopravvivenza 
cellulare, tutte e tre le isoforme del canale anionico voltaggio dipendente (VDAC, “voltage-
dependent anion channels”, una proteina della membrana mitocondriale esterna) hanno un ruolo 
equivalente nell‟accumulo mitocondriale di Ca2+ indotto da stimolazione con agonista, viceversa 
VDAC1, attraverso l‟intrerazione selettiva con i recettori dell‟inositolo trifosfato (IP3Rs) – 
un‟interazione ulteriormente rafforzata dagli stimoli apoptotici – è preferenzialmente coinvolto 
nella trasmissione ai mitocondri di stimoli apoptotici Ca
2+
 mediati che hanno entità inferiore, 
evidenziando un‟esclusiva via molecolare per il trasferimento del segnale Ca2+ ai mitocondri 
durante l‟apoptosi; ii) l‟oncosoppressore PML (leucemia promielocitica), quando localizzato al di 
fuori del nucleo, è comunque in grado di esercitare una funzione proapoptotica mediante la sua 
inaspettata localizzazione alle MAMs, dove PML è stato trovato in complessi proteici con i recettoti 
IP3R di tipo 3, la proteina chinasi Akt e la proteina fosfatasi PP2a, che sono essenziali per la 
modulazione dello stato di fosforilazione dell‟IP3R mediata da Akt e PP2a, e di conseguenza del 
rilascio di Ca
2+
 dall‟ER attraverso l‟IP3R; iii) l‟oncosoppressore PTEN (“phosphatase and tensin 
homolog deleted on chromosome 10”) localizza all‟ER e alle MAMs, e la quota di PTEN presente 
al reticolo è quella specificamente coinvolta nell‟aumento sia del trasferimento di Ca2+ dall‟ER ai 
mitocondri che nella suscettibilità a stimoli apoptotici mediati da Ca
2+
. 
L‟avanzamento nella conoscenza del funzionamento di proteine coinvolte nel segnale Ca2+ potrà 
rivelare nuovi inesplorati bersagli farmacologici ed aiutare nel trattamento del cancro ed altre 
patologie. 
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Abbreviations: 
 
m, mitochondrial membrane potential difference; 
AEQ, aequorin; 
ArA, arachidonic acid; 
ANT, adenine nucleotide translocase; 
Bap31, B-cell receptor-associated protein 31; 
BiP, Binding immunoglobulin Protein; 
Ca2+, calcium ions; 
[Ca2+], Ca2+ concentration; 
[Ca2+]c, cytosolic Ca
2+ concentration; 
[Ca2+]m, mitochondrial Ca
2+ concentration; 
CABPs, intraluminal Ca2+-binding proteins; 
CaMKII, calmodulin-dependent protein kinase II; 
Cyp D, cyclophilin D; 
Drp1, dynamin-related protein 1; 
ER, endoplasmic reticulum; 
ERp44, endoplasmic reticulum resident protein 44; 
ETO, etoposide; 
FACL4, long-chain fatty acid-CoA ligase type 4; 
FAD, familial Alzheimer‟s disease; 
Fis1, Fission 1 homologue; 
FRET, fluorescence resonance energy transfer; 
GFP, green fluorescent protein; 
GM1, GM1-ganglioside; 
grp75, glucose-regulated protein 75; 
HK, hexokinase; 
IMM, inner mitochondrial membrane; 
IMS, intermembrane space; 
IP3, inositol 1,4,5-trisphosphate; 
IP3R, inositol 1,4,5-trisphosphate receptor; 
Letm1, leucine zipper-EF-hand containing 
transmembrane protein 1; 
MAMs, mitochondria-associated membranes; 
MCU, mitochondrial Ca2+ uniporter; 
MICU1, mitochondrial calcium uptake 1; 
Mfn, mitofusin; 
VDAC, voltage-dependent anion channel; 
UCP, uncoupling protein; 
MEN, menadione; 
mHCX, mitochondrial H+/Ca2+ exchanger; 
mNCX, mitochondrial Na2+/Ca2+ exchanger; 
MOMP, mitochondrial outer membrane 
permeabilization; 
MPT, mitochondrial permeability transition; 
NCX, Na2+/Ca2+ exchanger; 
OA, okadaic acid; 
OMM, outer mitochondrial membrane; 
OPA1, optic atrophy 1; 
OXPHOS, oxidative phosphorylation; 
p66shc, 66-kDa isoform of the growth factor adapter 
shc; 
PACS-2, phosphofurin acidic cluster sorting protein 2; 
PAMs, plasma membrane associated membranes; 
PDH, pyruvate dehydrogenase; 
PI3K, phosphatidylinositol 3-kinase; 
PIP2, phosphatidylinositol 4,5-bisphosphate; 
PIP3, phosphatidylinositol 3,4,5-trisphosphate; 
PKA, protein kinase A; 
PKC, protein kinase C; 
PLC, phospholipase C; 
PMCA, plasma membrane Ca2+ ATPase; 
PML, promyelocytic leukemia protein; 
PP2a, protein phosphatase 2a; 
PS1, presenilin; 
PSS-1, phosphatidylserine synthase-1; 
PTEN, phosphatase and tensin homolog deleted on 
chromosome 10; 
PTP, permeability transition pore; 
ROS, reactive oxygen species; 
RyR, ryanodine receptor; 
SERCA, sarco-endoplasmic reticulum Ca2+ ATPase; 
Sig-1R, Sigma-1 receptor; 
SOCE, store-operated Ca2+ entry; 
SR, sarcoplasmic reticulum; 
TIRF, total internal reflection fluorescence; 
TG, thapsigargin; 
TN, tunicamycin; 
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1. INTRODUCTION: 
 
 
 
Changes in the levels of intracellular calcium ions (Ca
2+
) provide dynamic and highly versatile 
signals that regulates several processes as diverse as energy transduction, fertilization, secretions, 
muscle contraction, chemotaxis and neuronal synaptic plasticity in learning and memory (1). 
However, under certain conditions increases in intracellular Ca
2+
 are cytotoxic and lead to apoptosis 
(programmed cell death). Consequently, Ca
2+
 needs to be used in an appropriate manner to 
determine cell fate; if this balancing act is compromised, pathology may ensue (2). 
Ca
2+
 signalling proteins and organelles are emerging as additional cellular targets of oncogenes and 
tumour suppressors. The Ca
2+
 signal has major roles in the regulation of processes relevant to 
tumorigenesis, including migration, invasion, proliferation, and apoptotic sensitivity (3). 
Intracellular Ca
2+
  homeostasis has been the focus of researchers characterizing changes in Ca
2+
 
signalling in cancer cells. In order for the cancer cells to proliferate at higher rates and still protect 
themselves from apoptosis, many cancer cells remodel the expression or activity of their Ca
2+
 
signalling machinery. Spatially restricted Ca
2+
 signalling within specific cellular compartments or 
discrete cytosolic domains provides an additional layer of complexity in the regulation of cellular 
processes important in tumorigenesis. . In normal cells, the Ca
2+
 signalling is highly regulated 
spatially such as between endoplasmic reticulum (ER) and mitochondria, two intracellular 
organelles which play crucial roles in Ca
2+
 signalling and may decide the ultimate fate of the cell. 
Indeed, by adjusting the load of Ca
2+
 imposed upon the mitochondrion, the same Ca
2+
 efflux from 
ER (the main intracellular Ca
2+
 store) that is responsible for regulating processes for maintaining 
life could also act as a death-inducing signal. 
Since ER and mitochondria play significant roles in the regulation of cell proliferation and 
apoptosis, the remodelling of Ca
2+
 signalling machinery in ER and mitochondria in cancer cells 
seems imminent during oncogenic transformation. Therefore, targeting of the Ca
2+
 signalling 
apparatus in cancer cells could specifically disrupt their Ca
2+
 homeostasis, and so decrease cancer 
cell proliferation and increase cancer cell apoptosis. Such novel and highly innovative strategies can 
provide rationale and approaches for the design and development of novel technologies based on 
Ca
2+
 waves for the diagnosis and treatment of cancer, as well as other disease. 
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1.1 The Ca
2+
-signalling toolkit 
 
At the beginning of life, Ca
2+
 mediates the process of fertilization and regulates the cell cycle events 
during the early developmental processes. Once the cells differentiate to perform specific functions, 
changes in the levels of intracellular Ca
2+
 provide dynamic and highly versatile signals that control 
a plethora of cellular processes, yet under certain conditions increases in intracellular Ca
2+
 are 
cytotoxic (4). For this reason, the intracellular concentration of Ca
2+
, [Ca
2+
]i, in resting cells is 
usually maintained very low, at ~100 nM. 
In cells, due to the presence of several charged molecules, the Ca
2+
 diffusion rates are slow. In order 
to utilize Ca
2+
 as a second messenger, cells have devised an ingenious mechanism of signalling that 
has overcome the inherent problems associated with lower diffusion rates and potential cytotoxicity 
of Ca
2+
, by presenting changes in Ca
2+
 concentration as brief spikes which are often organized as 
regenerative waves (1). The universality of Ca
2+
-based signalling depends on its enormous 
versatility in terms of amplitude, duration, frequency and localization. The formation of the correct 
spatio-temporal Ca
2+
 signals is dependent on an extensive cellular machinery named the Ca
2+
 
toolkit, which includes the various cellular Ca
2+
-binding and Ca
2+
-transporting proteins, present 
mainly in the cytosol, plasma membrane, ER and mitochondria (5). 
To provide for a very fast and effective Ca
2+
-signaling, the cells use a great amount of energy to 
maintain an almost 20 000-fold Ca
2+
-gradient between their intracellular (~100 nM free) and 
extracellular (~1 mM) Ca
2+
 concentrations. To maintain this Ca
2+
 gradient, the cells chelate, 
compartmentalize, or remove Ca
2+
 from the cytoplasm  through its active extrusion by the plasma 
membrane Ca
2+
 ATPase (PMCA) and the Na
+
/Ca
2+
 exchanger (NCX) (6, 7) 
The increase of intracellular [Ca
2+
] can be elicited by two fundamental mechanisms (or a 
combination of both). The first involves Ca
2+
 entry from the extracellular milieu, through the 
opening of plasma membrane Ca
2+
 channels (traditionally grouped into three classes: voltage 
operated Ca
2+
 channels (VOCs) (8), receptor operated Ca
2+
 channels (ROCs) (9) and second 
messenger operated Ca
2+
 channels (SMOCs) (10)). The second universal mechanism for Ca
2+
 
signaling is the release of Ca
2+
 from intracellular Ca
2+
 stores, mainly the ER and its specialized 
form in muscle, the sarcoplasmic reticulum (SR). In these intracellular stores, two main Ca
2+
-
release channels exist that, upon stimulation, release Ca
2+
 into the cytosol, thus triggering Ca
2+
 
signalling: the inositol 1,4,5-trisphosphate (IP3) receptors (IP3Rs) and the ryanodine receptors 
(RyRs) (11, 12). IP3Rs are ligand-gated channels that function in releasing Ca
2+
 from ER Ca
2+
 
stores in response to IP3 generation. G protein coupled receptors (GPCRs) can activate 
phospholipase C β (PLCβ), and tyrosine-kinase receptors (TKR) can activate PLCγ, which then 
9 
 
cleave PIP2 into IP3 and diacylglycerol (DAG). IP3 binding to the IP3Rs that are present in the ER, 
causes efflux of Ca
2+
 from the ER to the cytoplasm resulting in increase in cytosolic Ca
2+
 
concentration ([Ca
2+
]c) from ~100 nM to ~1 M for several seconds (13, 14). This rise in [Ca
2+
]c 
results in various Ca
2+
-dependent intracellular events (Figure 1). A variety of cellular proteins with 
Ca
2+
-binding affinities ranging between nM to mM are utilized by the cells to buffer the cellular 
Ca
2+
 increase as well as to regulate cellular processes via Ca
2+
-signaling. The exact cellular 
outcome depends on the spatiotemporal characteristics of the generated Ca
2+
 signal (15).  
 
 
 
Figure 1. Regulation of multiple cellular processes by the IP3/Ca
2+
  signalling pathway. (figure from (16)) 
 
 
Once its downstream targets are activated, basal [Ca
2+
]c levels are regained by the combined 
activity of Ca
2+
 extrusion mechanisms, such as PMCA and NCX, and mechanisms that refill the 
intracellular stores, like sarco-endoplasmic reticulum Ca
2+
 ATPases (SERCAs) (6). Due to SERCA 
activity and  intraluminal Ca
2+
-binding proteins (CABPs), i.e., calnexin and calreticulin (17), the ER 
can accumulate Ca
2+
 more than a thousand-fold excess as compared to the cytosol. Given that 
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PMCAs pump Ca
2+
 out of the cell faster than it can be repleted, IP3R mediated efflux of Ca
2+
 from 
the ER in response to receptor activation empties the ER, thus  a Ca
2+
 entry mechanism is activated. 
This mechanism is called “Store-operated Ca2+ entry” (SOCE). The molecular determinants of 
SOCE have been identified in the very last few years and include the ER Ca
2+
 sensors STIM 
(stromal interaction molecule) 1 and  2, and the specialized plasma-membrane channels Orai1, 
Orai2 and Orai3 (for a recent review (18)). 
Although the ER (and its specialized form in muscle, the SR) is generally considered the main 
intracellular Ca
2+
 store, almost all other organelles play a role in Ca
2+
 signalling: mitochondria (see 
below) (19), the Golgi apparatus (20), secretory vesicles (21), lysosomes (22), endosomes (23) and 
peroxisomes (24, 25). 
Specificity in decoding Ca
2+
 signals can be provided by the affinity of Ca
2+
 sensor as well as its 
duration, amplitude and intracellular location: in this way a particular Ca
2+
 signal can specifically 
regulate many different cell functions (26). 
 
 
1.2 ER-mitochondria crosstalk: local microdomains support mitochondrial Ca
2+
 
uptake 
While the role of the ER as a physiologically important Ca
2+
 store has long been recognized, a 
similar role for mitochondria have seen a reappraisal only in the past two decades (27). The uptake 
of the Ca
2+
 ions into the mitochondrial matrix implies different transport systems responsible for the 
transfer of Ca
2+
 across the outer and the inner mitochondrial membrane (OMM and IMM 
respectively). It has long been known that mitochondria can rapidly accumulate Ca
2+
 down the large 
electrochemical gradient (mitochondrial membrane potential difference, m = -180 mV, negative 
inside) generated by the respiratory chain (28). Indeed, based on the chemiosmotic theory, the 
translocation by protein complexes of H
+
 across an ion-impermeable inner membrane generates a 
very large H
+
 electrochemical gradient and mitochondria employ the dissipation of this proton 
gradient not only to run the endoergonic reaction of ATP synthesis by the H
+
-ATPase, but also to 
accumulate cations into the matrix. 
For a long time, however, due to the low affinity of the mitochondrial Ca
2+
 uptake system under 
physiological conditions (an apparent Kd of 20 to 30 M under conditions thought to mimic the 
cytoplasm, estimated in the earlier work with isolated organelles) and the submicromolar global 
[Ca
2+
]c briefly reached after physiological stimulation (which rarely exceed 2-3 M), this process 
was considered to take place only in conditions of high-amplitude, prolonged [Ca
2+
]c increases, i.e. 
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in the Ca
2+
 overload that is observed in various pathological conditions (such as, for example, 
excitotoxic glutamate stimulation of neurons) (19). Mitochondrial Ca
2+
 returned to the limelight in 
1992 when Rizzuto, Pozzan and colleagues generated a novel, genetically encoded 
chemiluminescent indicator, aequorin. This probe, specifically targeted to the mitochondrial matrix, 
allowed dynamic, accurate and specific monitoring of the [Ca
2+
] within the matrix of mitochondria 
in living cells (29). With this new tool they could show that mitochondria in living cells undergo 
very fast and large increases in their matrix Ca
2+
 levels (mitochondrial Ca
2+
 concentration, [Ca
2+
]m) 
upon cell stimulation, reaching peaks similar or even larger than those in the cytoplasm, even for 
normal physiological cytoplasmic Ca
2+
 rises (30). Similar conclusions could be reached also with 
fluorescent indicators, such as the positively charged Ca
2+
 indicator rhod-2 (that accumulates within 
the organelle) (31) and the more recently developed GFP-based fluorescent indicators (32). 
While enlivening the interest in mitochondrial Ca
2+
 homeostasis, these data raised an apparent 
contradiction between the prompt response of the organelle (where [Ca
2+
]m rise, in a few seconds, to 
values above 10 M, and in some cell types up to 500 M) and the low affinity of the Ca2+ uptake 
system together with the low concentration of global Ca
2+
 signals observed in cytoplasm. Based on 
a large body of experimental evidence, it is now generally accepted that the key to the rapid Ca
2+
 
accumulation rests in the strategic location of a subset of mitochondria, close to the opening ER or 
plasma membrane Ca
2+
 channels (30, 31, 33). The hypothesis, called “microdomain hypothesis” 
(26), proposes that microdomains of high [Ca
2+
] (10-20 M) can be transiently formed in regions of 
close apposition between mitochondria and Ca
2+
 channels of the ER/SR or of the plasma membrane 
(33). These high Ca
2+
 microdomains rapidly dissipate (due to diffusion) insuring that mitochondria 
do not overload with Ca
2+
 (Figure 2). 
The “microdomain hypothesis” received a number of indirect confirmations in the last 20 years by 
different groups. More recently, such microdomains in selected regions of contact between ER and 
mitochondria were finally measured directly, by two complementary studies that demonstrated the 
existence and amplitude of high Ca
2+
 microdomains on the surface of mitochondria. Giacomello et 
al. (34) targeted a new generation of FRET-based Ca
2+
 sensors (35) to the OMM and, through a 
sophisticated statistical analysis of the images, revealed the existence of small OMM regions where 
[Ca
2+
] reaches values as high as 15-20 μM. The probe detected Ca2+ hotspots on about 10% of the 
OMM surface that were not observed in other parts of the cell. The Ca
2+
 hotspots were not uniform, 
and their frequency varied among mitochondria of the same cell. Moreover, classical 
epifluorescence and total internal reflection fluorescence (TIRF) microscopy experiments were 
combined in order to monitor the generation of high Ca
2+
 microdomains in mitochondria located 
near the plasma membrane. With this approach, it could be shown that Ca
2+
 hotspots on the surface 
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of mitochondria occur upon opening of VOCs, but not upon SOCE. Csordás et al. (36) used a 
complementary approach in which they generated genetically encoded bifunctional linkers 
consisting of OMM and ER targeting sequences connected through a fluorescent protein, including 
a low-Ca
2+
-affinity pericam, and coupled with the two components of the FKBP-FRB 
heterodimerization system (37), respectively. Using rapamycin-assembled heterodimerization of the 
FKBP-FRB-based linker, they detected ER/OMM and plasma membrane/OMM junctions (the latter 
at a much lower frequency). In addition, the recruited low-Ca
2+
-affinity pericam reported Ca
2+
 
concentrations as high as 25 M at the ER/OMM junctions in response to IP3-mediated Ca2+ 
release, which is in excellent agreement with the values obtained by Giacomello et al.. 
 
 
 
Figure 2. Intracellular Ca
2+
 signalling. Schematic model of intracellular Ca2+ homeostasis. Plasma membrane G-
protein coupled receptors activate phospholipase C-β (PLC-β) to promote the generation of inositol 1,4,5-trisphosphate 
(IP3) and the release of Ca2+ from the endoplasmic reticulum (ER) into the cytosol. Mitochondrial surface directly 
interacts with the ER through contact sites defining hotspots Ca2+ signalling units. Ca2+ import across the outer 
mitochondrial membrane (OMM) occurs by the voltage-dependent anion channel (VDAC), and then enters the matrix 
through the mitochondrial Ca2++ uniporter (MCU), the main inner mitochondrial membrane (IMM) Ca2+-transport 
system (Ca2+ levels reached upon stimulation are indicated in square brackets). Mitochondrial Ca2+ exchangers present 
in the IMM export Ca2+ from the matrix once mitochondrial Ca2+ has carried its function; another mechanism for Ca2+ 
efflux from mitochondria is the permeability transition pore (PTP). Ca2+ levels return to resting conditions (indicated in 
round brackets) through the concerted action of cytosolic Ca2+ buffers, plasma membrane Ca2+-ATPase (PMCA) and 
the Na+/ Ca2+ exchanger (NCX) that permit the ion extrusion in the extracellular milieu. Sarco-endoplasmic reticulum 
Ca2+ ATPase (SERCA) restablishes basal Ca2+ levels in intracellular stores. ANT adenine nucleotide translocase, Cyp 
D cyclophilin D, DAG diacylglycerol, PIP2 phosphatidylinositol 4,5-bisphosphate. 
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While based on cell morphology the close proximity between the mitochondria and the ER is 
expected and indeed often observed, i.e. in neuronal prolongings, a close interaction between ER-
resident Ca
2+
 channels and mitochondria in non-excitable cells implies the assembly of a dedicated 
signaling unit at the organelle interphase (see section 1.7). 
 
 
1.3 Calcium release from cellular store: structure and function of the IP3R 
The ER is possibly the largest individual intracellular organelle comprising a three dimensional 
network of endomembranes arranged in a complex grid of microtubules and cisternae. It is made up 
of functionally and structurally distinct domains (reviewed extensively by a number of authors (38-
41), in relation to the variety of cellular functions played by the organelle, primarily concerning 
protein synthesis, maturation and delivery to their destination (42, 43). Moreover, the ER is a 
dynamic reservoir  of Ca
2+
 ions, which can be activated by both electrical and chemical cell 
stimulation (44, 45) making this organelle an indispensable component of Ca
2+
 signalling (46-48). 
Modern analysis methods enabled the determination of the molecular profile of the ER. This profile 
reflects the ER‟s role in signalling, as it comprises a number of components constituting the Ca2+ 
signalling pathway. It contains IP3Rs, RyRs, SERCAs, and in addition to these release channels and 
pumps, there are buffers (calnexin, calreticulin) and a number of ancillary proteins (FK 506-binding 
proteins, sorcin, triadin, phosholamban) that contribute to the ER Ca
2+
 signalling system (49). 
Many extracellular stimuli, such as hormones, growth factors, neurotransmitters, neutrophins, 
odorants, and light, function generating IP3 through the phospholipase C isoforms, activated in 
different manners: G-protein coupled receptors (acting via PLC-β), tyrosine-kinase coupled 
receptors (PLC-γ), an increase in Ca2+ concentration (PLC-δ) or activated by Ras (PLC-ɛ) (50, 51). 
The final effector are the IP3Rs, nonselective cationic channels that conduct Ca
2+
. 
A functional IP3R Ca
2+
 channel is composed of tetramers with six transmembrane domains (of 
~3000 amino acids) that can be either homotetramers or, to a lesser extent, heterotetramers of 
different isoforms. From the structural point of view, several domains are recognized in the protein 
sequence, with different functions. These include the IP3-binding domain (IP3-BD), i.e. the 
minimal sequence sufficient for IP3 binding, located near the N-terminus of the protein (aa 226-
578). Interestingly, this protein domain contains armadillo-repeat protein structures that are engaged 
in protein-protein interactions, and mediates intramolecular interactions with other IP3R domains as 
well as the association with other regulatory proteins. N-terminally to the IP3-BD, i.e. within aa 1-
222, a suppressor region is located that inhibits ligand binding and thus lowers the global receptor 
IP3 affinity in the physiological range. The six transmembrane-spanning domain is at the very C-
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terminal end of each subunit, and, between them, an internal coupling domain assures the signal of 
IP3 binding is transferred to the channel-forming region, hence triggering its opening (52).  
Three isoforms of IP3R encoded by different genes have been identified with different agonist 
affinities and tissue distribution (53). Given that the affinity of the IP3-binding core to its ligand is 
similar for the three isoforms, the tuning of the whole receptor's affinity appears to be due to the 
isotype-specific properties of the N-terminal suppressor domain (54). 
The release of Ca
2+
 from the ER is a nonlinear, cooperative process wherein IP3 binds to four 
receptor sites on the IP3R, one on each subunit of the tetramer (52). IP3Rs are at first potentiated, 
then inhibited by Ca
2+
. Small perturbations in conditions, such as basal [Ca
2+
]i, [IP3], and various 
regulators can cause uncoordinated bursts of local release across a cell. The brief opening of IP3R 
channels gives rise to localized Ca
2+
 pulses, called “sparks” or “blips” and “puffs” (1). The smallest 
Ca
2+
 release events, “blips”, probably reflect random openings of single IP3R. Spontaneous 
clustering of IP3Rs (in particular of IP3R2, due to its higher IP3 affinity) have been proposed to be 
the underlying mechanism responsible for Ca
2+
 “puffs” observed in the cytoplasm (55). 
Recruitment of neighboring IP3Rs and combination of Ca
2+
 “puffs” results in Ca2+ waves, ensuring 
that the Ca
2+
 signal propagates to the entire cell (56), or remains confined to specific subcellular 
regions (57).  
Ca
2+
 oscillations, depend upon both the spatial organization of IP3Rs and their regulation by Ca
2+
, 
although the links between IP3R activities and Ca
2+
 oscillations are not fully understood. Ca
2+
 
regulates channel activity in a biphasic manner. Early studies demonstrated inhibition of IP3-
mediated Ca
2+
 mobilization by micromolar concentrations of Ca
2+
 (58). Lower concentrations were 
subsequently found to potentiate the effects of IP3 (59). In addition, also the ER Ca
2+
 content 
retains the capability to regulate the channel opening: in permeabilized hepatocytes, an increase in 
[Ca
2+
]er enhances the sensitivity of IP3R for its ligand, promoting also spontaneous Ca
2+
 release, but 
the nature of this direct regulation and the protein involved are still a matter of debate (60). In this 
context, the tight spatial relationship between ER and mitochondria, and the capacity of the latter to 
rapidly clear the high [Ca
2+
] microdomain generated at the mouth of the IP3R, makes mitochondria 
an active player in the control of IP3R function. The first clear demonstration of this concept came 
from the fine work of Lechleiter et al., who demonstrated that energized mitochondria, by 
regulating the kinetics of ER Ca
2+
 release, finely tune the spatio-temporal patterning of Ca
2+
 waves 
in Xenopus oocytes. Then, the observation that Ca
2+
 uptake by mitochondria controls the [Ca
2+
] 
microdomain at the ER/mitochondrial contacts and thus the kinetics of IP3R activation/inactivation 
was extended to a variety of mammalian cell lines, e.g. hepatocytes, astrocytes and BHK-21 cells, 
thus highlighting its general relevance (61). 
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Whereas IP3 and Ca
2+
 are essential for IP3R channel activation, other physiological ligands, such as 
ATP, are not necessary but can finely modulate the Ca
2+
-sensitivity of the channel (62). As for Ca
2+
, 
the modulation of IP3R by ATP is biphasic: at micromolar concentrations, ATP exerts a stimulatory 
effect, while inhibiting channel opening in the millimolar range (63, 64).  
Finally, in their coupling/suppressor domains, the IP3Rs possess consensus sequences for 
phosphorylation by numerous kinases; currently, at least 12 different protein kinases are known to 
directly phosphorylate the IP3R (65), among them: Akt (66), protein kinase A (cAMP-dependent) 
(67), protein kinase G (cGMPdependent) (68), calmodulin-dependent protein kinase II (CaMKII) 
(69), protein kinase C (PKC) (70), and various protein tyrosine kinases (71). 
 
 
1.4 Mitochondria: cell physiology and molecular nature of the mitochondrial 
Ca
2+
 uptake and release machinery 
 
Mitochondria: the basics 
The mitochondrion represents a unique organelle within the complex endomembrane systems that 
characterize any eukaryotic cell. Complex life on earth has been made possible through the 
“acquisition” of mitochondria which provide an adequate supply of substrates for energy-expensive 
tasks. The mitochondrion is a double membrane-bounded organelle thought to be derived from an 
-proteobacterium-like ancestor, presumably due to a single ancient invasion occurred more than 
1.5 billion years ago. The basic evidence of this endosymbiont theory (72) is the existence of the 
mitochondrial DNA (mtDNA), a 16.6 Kb circular double-stranded DNA molecule with structural 
and functional analogies to bacterial genomes (gene structure, ribosome). This mitochondrial 
genome encodes only 13 proteins (in addition to 22 tRNAs and 2 rRNAs necessary for their 
translation), all of which are components of the electron transport chain (mETC) complexes (I, III 
and IV), while the whole mitochondrial proteome consists of more than 1000 gene products. Thus, 
one critical step in the transition from autonomous endosymbiont to organelle has been the transfer 
of genes from the mtDNA to the nuclear genome. At the same time, eukaryotes had to evolve an 
efficient transport system to deliver nuclear-encoded peptides inside mitochondria: TIM 
(Transporters of the Inner Membrane), TOM (Transporters of the Outer Membrane) and 
mitochondrial chaperones (such as hsp60 and mthsp70) build up the molecular machinery that 
allows the newly-synthesized unfolded proteins to enter mitochondrial matrix (73). 
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Mitochondria are defined by two structurally and functionally different membranes: the plain outer 
membrane, mostly soluble to ions and metabolites up to 5000 Da, and the highly selective inner 
membrane, characterized by invaginations called cristae which enclose the mitochondria matrix. 
The space between these two structures is traditionally called intermembrane space (IMS), but 
recent advances in electron microscopy techniques shed new light on the complex topology of the 
inner membrane. Cristae indeed are not simply random folds but rather internal compartments 
formed by profound invaginations originating from very tiny “point-like structures” in the inner 
membrane (74). These narrow tubular structures, called cristae junctions, can limit the diffusion of 
molecule from the intra-cristae space towards the IMS, thus creating a micro-environment where 
mETC complexes (as well as other proteins) are hosted and protected from random diffusion. 
Mitochondria were identified as the powerhouse for energy production in eukaryotic cells thanks to 
decades of extensive biochemical work on carbohydrate metabolism and organelle morpho-
functional characterization, carried out in the first half of the 20th century by leading scientific 
figures such as Krebs, Corey, Claude, Palade and many others. Mitochondria are the main site of 
ATP production. When glucose is converted to pyruvate by glycolysis, only a small fraction of the 
available chemical energy has been stored in ATP molecules; the main enzymatic systems involved 
in this process are the tricarboxylic acid (TCA) cycle and the mETC. Products from glycolysis and 
fatty acid metabolism are converted to acetyl-CoA which enters the TCA cycle where it is fully 
degraded to CO2. More importantly, these enzymatic reactions generate NADH and FADH2 which 
provide reducing equivalents and trigger the electron transport chain. mETC consists of five 
different protein complexes: complex I (NADH dehydrogenase), complex II (succinate 
dehydrogenase), complex III (ubiquinol cytochrome c reductase), complex IV (cytochrome c 
oxidase) and complex V that constitutes the F1F0-ATP synthase. Electrons are transferred from 
NADH and FADH2 through these complexes in a stepwise fashion: as electrons move along the 
respiratory chain, energy is stored as an electrochemical H
+
 gradient across the inner membrane, 
thus creating a negative mitochondrial membrane potential (estimated around -180 mV against the 
cytosol). H
+
 are forced to reenter the matrix mainly through complex V which couples this proton 
driving force to the phosphorylation of ADP into ATP, according to the chemiosmotic principle. 
ATP is then released to IMS through the electrogenic Adenine Nucleotide Translocase (ANT) 
which exchange ATP with ADP to provide new substrate for ATP synthesis. Finally, ATP can 
easily escape the IMS thanks to the mitochondrial porin of the outer membrane, VDAC (voltage-
dependent anion channel). 
With the general acceptance of the chemiosmotic hypothesis, it has became clear that the  across 
the mitochondrial inner membrane is the driving force for mitochondrial Ca
2+
 accumulation (75). 
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Thus, Ca
2+
 enters the mitochondrial matrix down its electrochemical gradient, that can be generated 
either by the electron flow in the mETC or by reversal of the ATP synthase. Mitochondrial Ca
2+
 
accumulation plays a key role in the regulation of many cell functions, ranging from ATP 
production to cell death. Mitochondrial Ca
2+
 uptake and release is central not only for the regulation 
of cellular Ca
2+
 homeostasis, but is vital also for the regulation of intramitochondrial enzymes 
concerned with the utilization of oxidizable substrates. However, excess Ca
2+
 accumulation by 
mitochondria is a common event in the process of cell death, by both necrosis and apoptosis (76) 
(see , sections 1.5 and 1.6). 
Despite the basic mechanisms of mitochondrial Ca
2+
 homeostasis have been firmly established for 
decades, the molecular identities of the channels and transporters responsible for Ca
2+
 uptake and 
release (schematized in Figure 3) have remained mysterious until very recently. 
 
 
 
Figure 3. Schematic representation of the mitochondrial Ca
2+
, Na
+
 and H
+
 handling machinery. Ion fluxes are 
indicated by arrows. Red arrow, Ca2+; blue arrow, H+; green arrow, K+; yellow arrow, Na+. ETC, electron transport 
chain; Letm1, Leucine-zipper EF-hand containing transmembrane protein 1; MCU, mitochondrial Ca2+ uniporter; 
MICU1, mitochondrial calcium uptake 1; NCLX, Na+/Ca2+ exchanger; PTP, permeability transition pore; UCP2/3, 
uncoupling protein 2/3; VDAC, voltage-dependent anion channel (figure from (77)). See text for details. 
 
 
We and other groups extensively worked on this topic and what emerged was that the outer 
mitochondrial membrane (OMM, although traditionally considered freely permeable) is a critical 
determinant of the mitochondrial Ca
2+
 accumulation (78). Thus, the mitochondrial Ca
2+
 uptake 
machinery will be discussed, starting from the channels of the OMM, to the last identified 
components of the IMM. 
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Ca
2+
 transfer across the OMM 
The OMM was previously thought to be freely permeable for ions and small molecules, but now it 
is clear that the so-called voltage-dependent anion channels, VDAC, also reffered to as the 
mitochondrial porin, are major regulators of the various ion, nucleotide and molecule fluxes across 
this membrane, including the Ca
2+
 fluxes (79). 
Yeast possesses only one VDAC isoform (but has also another VDAC gene that correctly inserts 
into OMM showing no channel activity), while higher multicellular organisms and mammals have 
three distinct VDAC genes (VDAC1, VDAC2 and VDAC3), with VDAC1 representing the best 
characterized one. These three isoforms show a substantial sequence homology (from 65 to 75% in 
identity) and similar structure, with the only exception of VDAC2 that has a longer (11 aminoacids) 
N-terminal tail (80). Yeasts lacking VDAC gene cannot grow on non-fermentable medium, thus 
highlighting the relevance of this channel in mitochondrial function: reintroduction of any of the 
mammalian VDAC genes in this yeast strain can promptly restore growth defects (81, 82). 
VDAC can exist in multiple conformational states with different selectivity and permeability. This 
30-35 kDa protein, is traditionally considered as a large, high-conductance, weakly anion-selective 
channel, fully opened (pore diameter about 2.5 nm) at low potential (<20-30 mV), but switching to 
cation selectivity and lower conductance (the so-called “closed” state, with a smaller pore diameter 
of about 1.8 nm) at higher potentials (both positive and negative). When reconstituted into 
liposomes, each isoform induced a permeability with a similar molecular weight cut-off (between 
3400 and 6800 Da based on permeability to polyethylene glycol). Its structure, as determined by 
NMR and X-ray crystallography, consists of a 19-stranded β-barrel forming a pore with an inner 
diameter of about 1.5×1 nm and an N-terminal α-helix domain residing inside the pore: this 
segment most likely represents the voltage sensor since it is ideally positioned to regulate the 
conductance of ions and metabolites passing through the VDAC pore (83-85). As the main function 
of VDAC is assumed to be the gateway for ATP and metabolites, its “open” or “closed” states are 
defined with respect to those molecules (80, 86). However, the physiological relevance of the 
voltage gating properties of VDAC is still obscure and a matter of debate, since it requires the 
existence of a potential across the OMM. The existence of any membrane potential across the 
OMM has never been directly demonstrated (although some have assumed such a potential is not 
possible, others have proposed several clues in support of this hypothesis, as discussed in (87)). 
Despite this, a number of reports show that numerous cytosolic components can significantly 
modulate VDAC gating properties, including NADH (88), members of Bcl-2 protein family (89), 
metabolic enzymes (90), chaperones (91) and cytoskeletal elements (92). 
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A recent work by Tan and Colombini describes the higher permeability of VDAC to Ca
2+
 in the 
closed states (with low permeability to anionic metabolites), rather than the opened state. So VDAC 
closure seems to promote Ca
2+
 flux into mitochondria, with consequent permeability transition and 
cell death (see section 1.5), accordingly with previous observations that VDAC closure is a pro-
apoptotic signal (93, 94). These notions have a direct impact on mitochondrial Ca
2+
 transport, as 
variations in OMM permeability to Ca
2+
 can represent a bottleneck for the efficient ion transfer 
from the high [Ca
2+
] microdomain generated by the opening of the IP3R to the intermembrane 
space. Indeed, transient expression of VDAC in various cell types enhanced the amplitude of the 
agonist-dependent increases in mitochondrial matrix Ca
2+
 concentration by allowing the fast 
diffusion of Ca
2+
 from ER release sites to the inner mitochondrial membrane (78). As to the 
functional consequences, VDAC overexpressing cells are more susceptible to ceramide-induced cell 
death, thus confirming that mitochondrial Ca
2+
 uptake has a key function in the process of 
apoptosis. 
VDAC has been considered a master regulator of the apoptotic process: on one hand it was thought 
to be one of the main component of the permeability transition pore (PTP), the megachannel 
mediating the collapse of mitochondrial membrane potential during apoptosis; on the other side it 
has long been believed a key mediator of Bax-mediated release of cytochrome c (see sections 1.5 
and 1.6). However, despite the huge amount of work carried out on this protein, several recent 
papers (95-97) have raised serious doubt about our functional understandings of this channel. 
Indeed, new approaches mainly based on mice knockout models failed to clearly confirm any of the 
above mentioned functions and rather suggest that a substantial rethinking of VDAC roles is 
needed. 
 
Ca
2+
 transfer across the IMM 
Many attempts were made to identify the molecular nature of the mitochondrial Ca
2+
 uniporter 
(MCU), starting in the early 1970s, that is, soon after the discovery of mitochondrial Ca
2+
 function. 
MCU has always been described as an highly selective ion channel located in the IMM, with a 
dissociation constant 2 nM over monovalent cations, reaching saturation only at 
supraphysiological [Ca
2+
]c. Also Sr
2+
 and Mn
2+
 are conducted by MCU and the relative ion 
conductance is: Ca
2+Sr2+Mn2+Ba2+. Studies performed on isolated mitochondria allowed the 
identification of some regulatory molecules acting on MCU, in particular the most effective 
inhibitors are the hexavalent cation Rutenium Red (RuR) and its related compound RuR360; MCU 
is also modulated by aliphatic polyamines, such as spermine and aminoglycosides, and by the 
adenine nucleotides, in the order of effectiveness ATP>ADP>AMP (whereas the nucleoside 
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adenosine is ineffective) (98) as well as several plant-derived flavonoids (99). Another important 
regulator of MCU is Ca
2+
 itself. The apparent affinity of the MCU for Ca
2+
, under physiological 
conditions (i.e. 1 mM Mg
2+
), is very low (apparent Kd of 20-30 M) and the influx rate only 
becomes substantial when the extramitochondrial [Ca
2+
] reaches values above 5-10 M. As 
demonstrated by Moreau and its group (99), in fact, MCU has a biphasic dependence on [Ca
2+
]c 
increase, that can both activate or inactivate mitochondrial Ca
2+
 uptake. This mechanism allows the 
mitochondrial Ca
2+
 oscillation, but it prevents an excessive mitochondrial Ca
2+
 accumulation when 
intracellular Ca
2+
 elevation is prolonged. 
The MCU has been molecularly identified only very recently, preceded by the discovery of 
mitochondrial calcium uptake 1 (MICU1), an uniporter regulator which appears essential for 
mitochondrial Ca
2+
 uptake (100).  
The identification of MICU1 came from the establishment of the so-called MitoCarta database in 
which about 1000 proteins, specifically present in mitochondria, have been identified (many of 
them with unknown functions) (101). MICU1 is a 54-kDa protein, with only one putative 
transmembrane domain, which makes it unlikely that it can function as a Ca
2+
 channel, so it is not 
known whether it actually forms (part of) a Ca
2+
 channel, or functions as Ca
2+
 buffer, or as a Ca
2+
-
dependent regulatory protein acting as a Ca
2+
 sensor (it has a pair of Ca
2+
-binding EF-hand 
domains, the mutation of which eliminates the mitochondrial Ca
2+
 uptake). Taken together the 
above-mentioned characteristics suggest that MICU1 is not the channel-forming subunit of MCU 
itself, but rather an associated key subunit. 
Finally, last year, two indipendent papers identified the same protein, termed CCDC109A (coiled-
coil domaincontaining protein 109A) and renamed MCU, that possesses all the characteristics 
expected by the elusive Ca
2+
 uniporter of the IMM (102, 103). MCU is a 40-kDa protein  
ubiquitously expressed in all mammalian tissues and in most eukaryotes, but missing a yeast 
orthologue. MCU possesses two transmembrane domains and this characteristic makes it reasonable 
that it forms (through oligomerization) a gated ion channel. Downregulation of MCU drastically 
reduces mitochondrial Ca
2+
 uptake whereas transfection with the native channel rescues the 
phenotype of the specific siRNA-treated cells. Moreover, the other classical properties of 
mitochondria (that is, organelle shape and ER-mitochondrial interactions, O2 consumption, ATP 
synthesis and ) are not affected by MCU down-regulation. Just the protein‟s orientation is the 
mainly discrepancy between the two papers, one affirming a C-terminus localization in the 
intermembrane space (102), the other in the matrix (103). Importantly, thanks to the molecular 
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identification of the MCU, we can now expect a strong acceleration in the search for the functional 
role of this property of mitochondria, in both physiology and physiopathology. 
In the IMM are also present the mitochondrial Na
+
/Ca
2+
 exchanger (mNCX) and the H
+
/Ca
2+
 
exchanger (mHCX). Their main function is probably to export Ca
2+
 from the matrix once 
mitochondrial Ca
2+
 has carried out its function, to reestablish resting conditions (104). In spite of a 
few remarkable reports identifying the stoichiometry of the Na
+
/ Ca
2+
 exchanger (3 or 4 Na
+
 ions 
per Ca
2+
) (105), their molecular identity remained, until very recently, completely mysterious. They 
have yet to be identified, although recently strong evidence has been provided that the Na
+
/Ca
2+
 
exchanger isoform NCLX (until then considered an isoform of the PM Na
+
/ Ca
2+
 exchanger family) 
fulfils the criteria to be the elusive mitochondrial Na
+
-dependent Ca
2+
 efflux (106). They showed 
that practically all endogenous NCLX localizes in the mitochondrial fraction and knockout of 
NCLX drastically reduced Na
+
-dependent Ca
2+
 efflux in isolated mitochondria; moreover it is 
sensitive to the classical mitochondrial Na
+
/ Ca
2+
 exchanger inhibitor CGP-37157.  
Finally, the low conductance mode of the PTP, a channel of still debated nature localized in the 
IMM (107), can be also considered as a non-saturating mechanism for Ca
2+
 efflux from 
mitochondria. When open, PTP allows the passage of ions and molecules with a molecular weight 
up to 1.5 kDa, including Ca
2+
. Short-time openings may have a physiological function but its long-
time activation leads to the demise of the cell, either by apoptosis or by necrosis, depending on 
whether PTP opening occurs in only a small fraction of the mitochondria or in all of them (see the 
following section and references (108, 109)). 
 
 
1.5 Mitochondrial Ca
2+
 function 
 
Physiological functions of Ca
2+
 uptake in the mitochondria 
The first role assigned to the Ca
2+
 ions taken up into the mitochondrial matrix was the stimulation 
of the mitochondrial ATP production since important metabolic enzymes localized in the matrix, 
the pyruvate-, α-ketoglutarate- and isocitrate-dehydrogenases are activated by Ca2+, with different 
mechanisms: the first through a Ca
2+
-dependent dephosphorylation step, the others via direct 
binding to a regulatory site (110, 111). Those three enzymes represent rate-limiting steps of the 
Krebs cycle thus controlling the feeding of electrons into the respiratory chain and the generation of 
the proton gradient across the inner membrane, in turn necessary for ATP production through 
oxidative phosphorylation (OXPHOS). These events were directly visualized in intact, living cells 
using a molecularly engineered luciferase probe, which revealed an increase in the [ATP] of the 
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mitochondrial matrix following agonist stimulation and mitochondrial Ca
2+
 uptake (112). As the 
ATP produced by mitochondria is subsequently transferred to the cytosol, mechanisms that control 
ATP production will not only affect overall cell life but, more specifically, will regulate the activity 
of ATP-sensitive proteins localized in the close vicinity of mitochondria, such as IP3Rs and 
SERCA, which are stimulated by ATP (113, 114). The bidirectional relation between Ca
2+
 release 
and ATP production allows for a positive feedback regulation between ER and mitochondria during 
increased energetic demand (115). 
The uptake of Ca
2+
 in mitochondria will also affect Ca
2+
 signalling at both the local and the global 
level. Assuming the microdomain concept (30, 33), the local [Ca
2+
] will depend on both the amount 
of Ca
2+
 released by IP3Rs and that taken up by mitochondria. Since both SERCA pumps and IP3Rs 
are also regulated by Ca
2+
, the local [Ca
2+
] in the vicinity of mitochondria will determine the 
refilling of the ER and eventually the spatiotemporal characteristics of the subsequent Ca
2+
 signals 
(116). This will in turn depend on the exact subcellular localization of mitochondria, as well as the 
efficiency of the coupling between the ER and the mitochondrial network (117). In some 
conditions, the presence of mitochondria can completely block the further propagation of a Ca
2+
 
signal through the cytoplasm. In pancreatic acinar cells, the mitochondria serve as efficient 
firewalls, absorbing cytosolic Ca
2+
 signals. As a result, the propagation of the Ca
2+
 signal will be 
limited to the apical pole of the cell and will be prohibited from entering the nucleus (117). The 
local Ca
2+
 concentration can also affect mitochondrial motility and ER-mitochondria associations in 
various ways, hence the connection between mitochondria and the ER can be highly dynamic (118). 
Proteins involved in mitochondrial movement along microtubules, dynein and kinesin, are prone to 
high [Ca
2+
]c mediated by a Ca
2+
 sensor. As the mitochondrial motility is inhibited by Ca
2+
 levels in 
the low micromolar range, it means that mitochondria will be trapped in the neighbourhood of 
active Ca
2+
-release sites allowing for a more efficient Ca
2+
 uptake (119, 120). Apart from organelles 
movement, mitochondria also continuously remodel their shape. Many of the gene products 
mediating the fission and fusion processes have been identified in yeast screens, and most are 
conserved in mammals, including the fission mediators dynamin-related protein 1 (Drp1, Dnm1 in 
yeast) and Fis1 (Fission 1 homologue), as well as the fusion mediators mitofusins (Mfn) 1 and 2 
(Fzo1 in yeast) and optic atrophy 1 (OPA1, Mgm1 in yeast) (121). Several previous studies have 
indicated that elevation of [Ca
2+
]c perturbs mitochondrial dynamics (122), and more recent works 
have clearly demonstrated that mitochondrial shape can be controlled by an ER-dependent 
signalling pathway (123, 124). Mitochondria also undergo a more „macroscopic‟ remodelling of 
their shape during programmed cell death: after apoptosis induction, mitochondria become largely 
fragmented, resulting in small, rounded and numerous organelles. However, the relationship 
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between mitochondrial fusion/fission and apoptosis is complex and mitochondrial fragmentation is 
not necessarily related to apoptosis (125).  
Finally, mitochondria may play an even more active part in Ca
2+
 signaling since the ions can 
propagate through the mitochondrial network, allowing for mitochondrial release of Ca
2+
 at a 
distance of the original uptake site (126). 
 
Mitochondrial Ca
2+
 overload 
Although Ca
2+
 uptake in the mitochondria is crucial for vital cell functions, there exists a risk of 
mitochondrial Ca
2+
 overload, which may result in the induction of cell death (Figure 4). There are 
two pathways that can lead to apoptosis, the death receptor pathway (extrinsic apoptotic pathways) 
and the mitochondrial pathway (intrinsic apoptotic pathways), both converging on the activation of 
the executioner caspases (127). 
The mitochondrial IMS contains many pro-apoptotic factors such as cytochrome c, apoptosis-
inducing factor (AIF), Smac/Diablo, HtrA2/Omi and endonuclease G (EndoG). These are released 
from mitochondria to the cytosol in response to apoptotic signals (for a review see (128)). Released 
pro-apoptotic proteins can initiate three signalling cascades leading to apoptosis: i) released 
cytochrome c, together with pre-existing cytosolic apoptosis protease activating factor 1 (APAF-1) 
forms the “apoptosome”, which results in the activation of procaspase-9 and in turn activation of 
effector caspases (caspases-3, -6, and -7), the primarily responsible for the cleavage of cellular 
proteins leading to the biochemical and morphological characteristics of apoptosis; ii) released 
Smac/DIABLO and Omi/HtrA2 favour caspase activation by antagonizing the endogenous inhibitor 
of apoptosis (IAP) proteins in the cytosol; and iii) released AIF and EndoG favour DNA 
fragmentation and chromatin condensation.  
The release of pro-apoptotic factors is preceded by the OMM permeabilization, a crucial step in 
apoptosis. However, the exact mechanism of mitochondrial OMM permeabilization is not yet clear 
(129). Ca
2+ 
is a critical sensitizing signal in the pro-apoptotic transition of mitochondria, that plays a 
key role in the regulation of cell death. At a high concentration, mitochondrial Ca
2+
 stimulates 
drastic changes in mitochondrial morphology and functional activity due to the opening of a non-
specific pore, commonly known as the PTP, a mitochondrial megachannel likely to be located in the 
inner-outer contact sites of the mitochondrial membranes (108). This event, also known as 
mitochondrial permeability transition (MPT), leads to osmotic swelling of the mitochondria, loss of 
their membrane potential, and rupture of the OMM, causing the release of IMS proteins, including 
cytochrome c, into the cytosol (129, 130). This process can be facilitated by inorganic phosphate, 
oxidation of pyridine nucleotides, ATP depletion, low pH, and ROS. The PTP is generally believed 
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to be a multimeric complex, composed of VDAC in the OMM, ANT in the IMM, and a matrix 
protein, cyclophilin D (CypD). Ca
2+
 binding to cyclophilin D positively regulates PTP opening and 
in turn cell death (131). However, the molecular nature of the PTP is still unresolved (108). An 
important point hereby was the demonstration that the MPT was not affected by the genetic ablation 
of any or all of the 3 VDAC isoforms (95). PTP opening may ultimately also lead to necrosis, if 
MPT and subsequent uncoupling of mitochondria occur in a large subpopulation of these 
organelles; indeed the border between apoptotic and necrotic cell death is quite diffuse. 
Mitochondrial membrane permeabilization can also result from a distinct, yet partially overlapping 
process known as mitochondrial outer membrane permeabilization (MOMP) (128). In MOMP, pro-
apoptotic members of the B-cell CLL/lymphoma-2 (Bcl-2)-protein family may form protein-
permeable pores in the OMM (for example, by binding to the VDAC channels and regulating their 
properties or by forming multimeric channel complexes (132)), causing the release of IMS proteins 
into the cytosol. Moreover, Bcl-2 family members function as regulators of Ca
2+
 signalling; this 
important aspect will be discussed in the following section (the interested reader should also refer to 
(133)).  
 
 
1.6 Remodelling ER-mitochondria Ca
2+
 transfer in cell survival and death 
ER and mitochondria functions are intimately connected. A major area of functional interaction 
between the ER and mitochondria is the control of Ca
2+
 signalling, that is a topic of major interest 
in physiology and pathology. These two organelles form a highly dynamic interconnected network 
within which they cooperate to generate Ca
2+
 signals. The mitochondria play an important role in 
shaping the Ca
2+
 signal released from the ER. During normal signalling, there is a continuous flow 
of Ca
2+
 between these two organelles. The normal situation is for most of the Ca
2+
 to reside within 
the lumen of the ER except during Ca
2+
 signalling when a small bolus is periodically released to the 
cytoplasm and is then re-sequestered with a proportion passing through the mitochondria. At 
equilibrium, therefore, the bulk of internal Ca
2+
 is in the ER where it not only functions as a 
reservoir of signal Ca
2+
 but it also plays an essential role in maintaining the activity of the 
chaperones responsible for protein processing (26). However, despite controlling many processes 
essential for life, Ca
2+
 arising from the ER can be a potent death-inducing signal (134, 135). 
The release of Ca
2+
 from ER stores by IP3Rs has been implicated in multiple models of apoptosis as 
being directly responsible for massive and/or a prolonged mitochondrial Ca
2+
 overload. The 
requirement of IP3Rs for Ca
2+
-dependent cell death is exemplified by the resistance to apoptosis of 
cells in which InsP3R expression has been ablated or reduced (136, 137). Mitochondria seem to be 
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the downstream effectors of this pathway, as KO of IP3R3 significantly decreased agonist-induced 
mitochondrial Ca
2+
 uptake (138). In this picture, the three isoforms of the IP3R appear to play 
distinct roles. IP3R3 seems to play a selective role in the induction of apoptosis by preferentially 
transmitting apoptotic Ca
2+
 signals into mitochondria, whereas IP3R1 predominantly mediates 
cytosolic Ca
2+
 mobilization (139, 140). However, other studies have shown that the type 1 isoform 
can also mediate apoptosis (141). 
Several observations underline the significance of the role of the ER-mitochondrial Ca
2+
 flux in 
stimulating apoptosis. Indeed, a wide number of apoptotic stimuli, such as ceramide, arachinodic 
acid, and oxidative stress induced by H2O2 or menadione, trigger both a progressive release of Ca
2+
 
from the ER and an activation of the capacitative Ca
2+
 influx (142, 143). This sustained ER Ca
2+
 
release, in turn, induced a mitochondrial Ca
2+
 overload with a consequent release of mitochondrial 
proteins involved in the apoptotic process (Figure 4). 
 
 
 
Figure 4. Differential decoding of Ca
2+
-linked stimuli evoking the activation of cell metabolism or apoptosis. (figure 
modified from (135) 
 
 
Since ER and mitochondria play significant roles in the regulation of cell proliferation and 
apoptosis, the remodeling of Ca
2+
 signaling machinery in ER and mitochondria of cancer cells 
seems imminent during oncogenic transformation, to limit death-inducing Ca
2+
 signals during 
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cancer. The first indication came from the observation that in cancer cells the increased expression 
of anti-apoptotic members of the Bcl-2 family of proteins (Bcl-2 and Bcl-XL), or decreased 
expression of the pro-apoptotic BH3-only proteins (Bax or Bak) can protect these cells from 
apoptosis by modulating intracellular Ca
2+
 signals. These proteins reside in the ER, cytosol and 
mitochondria as homo o heterodimers. Of interest, the proapoptotic protein Bcl-2 affects ER-
mitochondrial Ca
2+
 crosstalk, as the over-expression of Bcl-2 reduces the Ca
2+
 content of the ER 
(144) making the cells resistant to apoptosis. Similarly, genetic ablation of the proapoptotic proteins 
Bax and Bak that drastically increases the resistance to death signals also results in a dramatic 
reduction in ER Ca
2+
 content, and consequently in a reduction of the Ca
2+
 that can be transferred to 
mitochondria (143). The use of a Bax/Bak double-knockout model system demonstrated that Bcl-2 
forms a macromolecular complex with the IP3Rs. The decreased level of Bax and Bak hereby 
correlated inversely with the amount of Bcl-2 bound to the IP3R, the phosphorylation status of the 
IP3R and the Ca
2+
 leak from the ER, leading to the conclusion that Bcl-2 regulated ER Ca
2+
-store 
content by regulating the phosphorylation status and the activity of the IP3R. The phosphorylation 
of IP3R1 was proposed to be due to protein kinase A, but the role of other kinases could not be 
dismissed (145). 
IP3R phosphorylation appears to be a key common feature for modulation of channel function and, 
as consequence, apoptotic signalling. IP3Rs possess consensus sequences for phosphorylation by 
numerous kinases, including the pro-survival protein kinase Akt. The consensus site for 
phosphorylation by Akt has been identified at the carboxyl terminus (serine 2618) of all three 
mammalian IP3R isoforms and is conserved from mammals to flies (66). This phosphorylation 
event decreases IP3-stimulated Ca
2+
 release from the ER and so diminishes flux of Ca
2+
 to the 
mitochondria following stimulation with pro-apoptotic agonists, thereby reducing apoptosis (146, 
147). This is an interesting observation, because in some cancer cells in which Akt is constitutively 
active (e.g. prostatic carcinoma cells), IP3Rs are hyper-phosphorylated (66). These data suggest that 
this functional interaction between Akt and IP3Rs is retained in tumour cells, endowing them with a 
significant survival advantage by limiting Ca
2+
-dependent death signalling. 
ER-mitochondria Ca
2+
 transfer appears to be a key sensitizing in various apoptotic routes. Hence, 
therapeutic modulation of targets that regulate [Ca
2+
]er and/or ER-mitochondrial Ca
2+
 transfer may 
be able to augment apoptosis in cancer cells without disrupting global Ca
2+
 homeostasis. However, 
the precise molecular definition of this process still awaits a fine clarification of the macromolecular 
complex assembled at the interphase between the two organelles. As will be discussed shortly, 
significant research efforts have been made to shed some light on this signalling pathway, and this 
was also the main aim of this thesis project. 
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1.7 Mitochondria-associated membranes: role of structural and regulatory 
proteins in the control of Ca
2+
 transfer between ER and mitochondria 
The association between ER and mitochondria was first described by Copeland and Dalton over 50 
years ago in pseudobranch gland cells (148). By the beginning of the 70s, the contacts between 
mitochondria and ER had been visualized by several groups (149, 150). Electron micrograph 
images of quickly frozen samples (151) and experiments in living cells with the two organelles 
labelled by means of targeted spectral variants of GFP (mtBFP and erGFP) (33), demonstrated 
conclusively that such physical interactions between the two organelles indeed exist. These latter 
experiments revealed the presence of overlapping regions of the two organelles and allowed to 
estimate the area of the contact sites as 5-20% of the total mitochondrial surface (Figure 5). The 
distance between the ER and the OMM was originally estimated to be approximately 100 nm (152, 
153). More detailed morphological studies, carried out by Achleitner et al. in 1999, indicated that 
the distance between the ER and mitochondria in the areas of interaction varied between 10 and 60 
nm (154). Importantly, a direct fusion between membranes of the ER and mitochondria was not 
observed in any case, and the membranes invariably maintained their separate structures. The 
authors of this pioneering paper proposed that a distance of less than 30 nm between the two 
organelles could be considered as an association. More recently, electron tomography techniques 
allowed to estimate that the minimum distance is even shorter (e.g., 10-25 nm) (155). This distance 
thus enables ER proteins to associate directly with proteins and lipids of the OMM. Further 
development of microscopic techniques enabled detailed analysis of such contacts with high 
resolution in three dimensions (156). 
The interactions between ER and mitochondria at the contact sites are so tight and strong, that upon 
subcellular fractionation (at the step of mitochondria purification), a unique fraction, originally 
named „mitochondria-associated membranes” (MAMs), can be isolated (157, 158). More recently, 
the isolation procedures was improved and adapted to isolate the MAMs fraction from yeast, 
different organs, tissues, and various cell lines (154, 159, 160). The molecular analysis of both 
“crude” mitochondria and MAMs fractions demonstrated that, apart from specific ER and 
mitochondrial proteins, they also contain proteins which are abundant in the plasma membrane. 
However, research on the morphological organization of mitochondria and ER with respect to the 
plasma membrane is much less extensive. Modifications in the subcellular fractionation procedure 
enabled the isolation of the “plasma membrane associated membranes” (PAMs) fraction. In general, 
PAMs fractions have been described as the center of interactions between plasma membrane and 
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the ER (161, 162), but the presence of mitochondrial proteins in these fractions indicates that 
mitochondria interact actively also with the plasma membrane (163, 164). 
 
 
 
Figure 5. High-resolution 3D imaging of ER-mitochondria contact sites.  Combined 3D imaging of mitochondria and 
ER in a HeLa cell transiently expressing mtGFP(Y66H,Y145F) and erGFP(S65T). The mitochondrial and ER images 
are represented in red and green, respectively; the overlaps of the two images are white. On the bottom, a detail of the 
main image (80-nm pixel) (figure from (33)  
 
The MAMs have a pivotal role in several cellular functions related to bioenergetics and cell 
survival. MAMs have been originally shown to be enriched in enzymes involved in lipid synthesis 
and trafficking between ER and mitochondrial membranes, including long-chain fatty acid-CoA 
ligase type 4 (FACL4) and phosphatidylserine synthase-1 (PSS-1) (158, 165, 166). The MAMs 
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have since been shown to be enriched in functionally diverse enzymes involved not only in lipid 
metabolism but also in glucose metabolism (for recent reviews, see (167, 168)). 
More recently, the same subcellular fraction has been shown to contain Ca
2+
-sensing ER chaperones 
and oxidoreductases, as well as key Ca
2+
 handling proteins of both organelles (169, 170). Together, 
these data have led to the conclusion that the MAMs are not only a site of lipid synthesis and 
transfer, but also function as a fundamental hub of cellular signalling that controls a growing 
number of processes associated with both organelles, ranging from ER chaperone-assisted folding 
of newly synthesized proteins to the fine-tuning of physiological and pathological Ca
2+
 signals from 
ER to mitochondria. 
Ca
2+
-handling proteins such as IP3Rs (especially type 3 IP3Rs) and VDAC are highly 
compartmentalized at MAMs (139), identifying these zones as „hotspots‟ of Ca2+ transfer from the 
ER to the closely adjacent mitochondrial network (31, 33). Ca
2+
 signals arising from the ER are 
vital for regulating Ca
2+
 levels in mitochondria, and so the activation of cell metabolism or 
apoptosis. Therefore, ER Ca
2+
 handling at MAMs acts as a double-edged sword, suggesting the 
existence of still not fully elucidated regulatory mechanisms, that are capable of discriminating 
between signals of life or death.  
Several proteins may participate in the stabilization of MAMs and, in this way, affect Ca
2+
 transfer 
between ER and mitochondria, while other proteins may be directly involved in regulating Ca
2+
-
transport proteins. During the last years, research has focused on the identification of connecting 
structures between the ER and mitochondria at the MAMs, revealing that the interactions between 
the two organelles seem to be modulated both by a family of chaperone proteins and by a family of 
“mitochondria-shaping proteins”. One of the first advances was made in 2006, when Csordás et al. 
showed by electron tomography that ER and mitochondria are adjoined by tethers seemingly 
composed of proteins, since the in vitro incubation with proteinase not only detached the ER from 
mitochondria, but also disrupted Ca
2+
 transfer. Tightening of the connections sensitized 
mitochondria to Ca
2+
 overloading, ensuing permeability transition, and seemed relevant for several 
mechanisms of cell death. Thus, these results revealed an unexpected dependence of cell function 
and survival on the maintenance of a proper spacing between the ER and mitochondria (155). 
At the same time, Szabadkai et al. found that the mitochondrial chaperone grp75 (glucose-regulated 
protein 75) mediates the molecular interaction of VDAC with the ER Ca
2+
-release channel IP3R. It 
was demonstrated that grp75 not only induces a chaperone-mediated conformational coupling of the 
proteins, but also allowed for a better transfer of the Ca
2+
 ions from the ER to the mitochondrial 
matrix (171). In support of this view, we previously demonstrated that the overexpression of VDAC 
enhances Ca
2+
 signal propagation into the mitochondria, increasing the extent of mitochondrial Ca
2+
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uptake (also leading to a higher susceptibility for ceramide-induced cell death), acting at the ER-
mitochondria contact sites (78). Moreover, one aim of my PhD Programme was the analysis of the 
contribution of the different VDAC isoforms to global cellular Ca
2+
 homeostasis, in order to 
establish the role of this non-redundant molecular route in transferring Ca
2+
 signals to mitochondria 
in apoptosis. The results (presented in section 3.1 and in Reference (172)) demonstrate that 
VDAC1, but not VDAC2 and VDAC3 isoforms, selectively interacts with IP3Rs; this interaction is 
further strengthened by apoptotic stimuli and thus VDAC1 is preferentially involved in the 
transmission of the low-amplitude apoptotic Ca
2+
 signals to mitochondria (172). 
Also, ER chaperones, particularly the Ca
2+
-binding chaperones calnexin, calreticulin, Sigma-1 
receptor (Sig-1R) and Binding immunoglobulin Protein (BiP, also known as the glucose-regulated 
protein GRP78), have been found to be compartmentalized at the MAMs, yielding a new picture 
whereby chaperone machineries at both ER and mitochondria orchestrate the regulation of Ca
2+
 
signalling between these two organelles. For instance, calnexin reversibly interacts with SERCA2b 
to block Ca
2+
 import (173). Similarly, calreticulin inhibits Ca
2+
 uptake by inhibiting its affinity for 
the SERCA2b pump, but also regulates IP3-induced Ca
2+
 release (17, 174). In vivo, these functions 
of calreticulin may be more crucial for survival than its chaperone activity, since calreticulin-
deficient cells have impaired Ca
2+
 homoeostasis (175, 176). 
Back in 2005, Simmen et al. reported the identification of a multifunctional cytosolic sorting 
protein, PACS-2 (phosphofurin acidic cluster sorting protein 2), that partially resides in the MAMs 
and maintains their integrity (177). PACS-2 depletion induces mitochondria fragmentation and 
uncouples these organelles from the ER, raising the possibility that, in addition to mediating MAMs 
formation, PACS-2 might also influence Ca
2+
 homeostasis and apoptosis. Indeed, it has been shown 
that IP3Rs (and RyRs) possess potential PACS-2-binding sites (178); hence, disruption of PACS-2 
may cause mislocalization of IP3Rs, resulting in reduced Ca
2+
 transfer from the ER to 
mitochondria. Moreover, in response to apoptotic stimuli, PACS-2 has been demonstrated to be 
capable of inducing Bid recruitment to mitochondria, an event that leads to cytochrome c release 
and caspase 3 activation (177). PACS-2 also interacts with and regulates the distribution and 
activity of calnexin. Under control conditions, >80% of calnexin localizes to the ER, mainly at the 
MAMs. However, through a protein-protein interaction, PACS-2 causes calnexin to distribute 
between the ER and the plasma membrane, affecting ER Ca
2+
 homeostasis (179). PACS-2 and 
calnexin also interact with the MAMs-resident ER cargo receptor Bap31 (B-cell receptor-associated 
protein 31) and regulate its cleavage during the triggering of apoptosis (180). Despite these 
observations, the exact role of PACS-2 in the regulation of Ca
2+
 transfer from the ER to the 
mitochondria remains to be further investigated. 
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Recently, Simmen‟s group have also shown that the GTPase Rab32, a member of the Ras-related 
protein family of Rab, localizes to the ER and mitochondria and identified this protein as a regulator 
of MAMs properties. Its activity levels control MAMs composition, destroying the specific 
enrichment of calnexin at the MAMs, and consequently ER calcium handling. Furthermore, as a 
PKA-anchoring protein, Rab32 determines the targeting of PKA to mitochondrial and ER 
membranes, resulting in modulated PKA signalling. Together, these functions result in a delayed 
apoptosis onset with high Rab32 levels and, conversely, accelerated apoptosis with low Rab32 
levels, explaining the possible mechanism by which it could act as an oncogene (181). 
Also Sig-1R, an ER chaperone serendipitously identified in cellular distribution studies by Hayashi 
and Su, is enriched in the MAMs and seems to be involved in Ca
2+
-mediated stabilization of IP3Rs 
(138). Under normal conditions in which the ER luminal Ca
2+
 concentration is at 0.5-1.0 mM, it 
selectively resides at the MAMs and forms complexes with the ER Ca
2+
-binding chaperone BiP. 
Upon the activation of IP3Rs, which causes the decrease of the Ca
2+
 concentration at the MAMs, 
Sig-1R dissociates from BiP to chaperone IP3R, which would otherwise be degraded by 
proteasomes. Thus, Sig-1R appears to be involved in maintaining, on the ER luminal side, the 
integrity of the ER-mitochondrial Ca
2+
 cross-talk, as demonstrated by the fact that its silencing 
leads to impaired ER-mitochondrial Ca
2+
 transfer. Sig-1R has been implicated in several neuronal 
and non-neuronal pathological conditions (182),  and is also upregulated in a wide variety of tumour 
cell lines (183). Therefore, degenerative neurons or tissue might benefit by Sig-1R agonists which 
promote cell survival (184, 185); conversely, its antagonists inhibit tumour-cell proliferation (186). 
Another example of a folding enzyme regulating ER Ca
2+
 content is the oxidoreductase ERp44 
(endoplasmic reticulum resident protein 44) that interacts with cysteines of the type 1 IP3R, thereby 
inhibiting Ca
2+
 transfer to mitochondria when ER conditions are reducing (187). Recent results 
suggest that another oxidoreductase, Ero1α, might also perform such a function, since Ero1α 
interacts with the IP3R and potentiates the release of Ca
2+
 during ER stress (188). This function of 
Ero1α could impact the induction of apoptosis that critically depends on ER-mitochondria Ca2+ 
communication (139, 189). Gilady et al. showed that, despite Ero1α being an ER luminal protein, 
the targeting of Ero1α to the MAMs is quite stringent (>75%), consistent with its role in the 
regulation of Ca
2+
 homeostasis. Moreover, they found that localization of Ero1α on the MAMs is 
dependent on oxidizing conditions within the ER; indeed, hypoxia leads to a rapid and eventually 
complete depletion of Ero1α from the MAMs (190). 
In the increasingly clear but complex picture that is emerging for MAMs, also the mitochondrial 
fusion protein Mfn2 has been shown to be enriched at contact sites between the ER and 
mitochondria. Mfn2 on the ER appeared to link the two organelles together: the connection 
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depended on the interaction of the ER Mfn2 with either Mfn1 or Mfn2 on the OMM (156). 
Moreover, its absence changes not only the morphology of the ER but also decreased by 40% the 
interactions between ER and mitochondria, thus affecting the transfer of Ca
2+
 signals to 
mitochondria. This may contribute to the Charcot-Marie-Tooth neuropathy type 2a in which 
missense mutations occur in Mfn2 (191). A too strong ER-mitochondria interaction, and the 
concomitant improved Ca
2+
 transfer between the two organelles, may also be detrimental as 
overexpression of Mfn2 led to apoptosis in vascular smooth-muscle cells (192). A recent report also 
propose the keratin-binding protein Trichoplein/mitostatin (TpMs), often downregulated in 
epithelial cancers (193), as a new regulator of mitochondria-ER juxtaposition in a Mfn2-dependent 
manner (194). 
Also the mitochondrial fission protein Fis1 has been involved in ER-mitochondria coupling. Fis1 
physically interacts with Bap31, an integral membrane protein expressed ubiquitously and highly 
enriched at the outer ER membrane, to bridge the mitochondria and the ER, setting up a platform 
for apoptosis induction. It appeared that the Fis1-Bap31 complex is required for the activation of 
procaspase-8. Importantly, as this signalling pathway can be initiated by Fis1, the Fis1-Bap31 
complex establishes a feedback loop by releasing Ca
2+
 from the ER that is able to transmit an 
apoptosis signal from the mitochondria to the ER (195). 
Apoptosis is a process of major biomedical interest, since its deregulation is involved in the 
pathogenesis of a broad variety of disorders (neoplasia, autoimmune disorders, viral and 
neurodegenerative diseases, to name a few). The key process connecting apoptosis to ER-
mitochondria interactions is an alteration in Ca
2+
 homeostatic mechanisms that results in massive 
and/or a prolonged mitochondrial Ca
2+
 overload (Figure 6).  
Mitochondrial Ca
2+
 is therefore a central player in multiple neurodegenerative diseases such as 
Alzheimer's disease (AD), Parkinson's disease and Huntington's disease (196). It is noteworthy that 
alteration in Ca
2+
 homeostasis in sporadic AD patients started being reported in the middle of the 
1980s, albeit in contrasting ways. Interestingly, very recent data have revealed that presenilin-1 
(PS1) and presenilin-2 (PS2), two proteins that, when mutated, cause familial AD (FAD), have a 
strong effect on Ca
2+
 signalling (sometimes yielding contradictory experimental findings, as 
recently reviewed in (197)). Of particular interest on this topic, is the report that MAMs are the 
predominant subcellular location for PS1 and PS2, and for γ-secretase activity (198). Moreover, it 
has recently been found that PS2 over-expression increases the interaction between ER and 
mitochondria and consequently Ca
2+
 transfer between these two organelles, an effect that is greater 
in FAD variants (199). It is possible to speculate that this favoured interaction could potentially 
result in a toxic mitochondrial Ca
2+
 overload. A defect in Ca
2+
 signalling due to altered MAMs 
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function could explain the well-known disturbances in Ca
2+
 homeostasis in AD (200, 201). It also 
opens the door to new ways of thinking about complementary treatment; in addition, it may be 
possible to exploit aberrant MAMs function as a useful marker for the development of a diagnostic 
tool for AD (202). 
Sano et al. also demonstrated that in GM1-gangliosidosis, a neurodegenerative disease, GM1-
ganglioside (GM1) accumulates in brain within the MAMs, where it specifically interacts with 
phosphorylated IP3R1, influencing its activity (203). GM1 has been previously shown to modulate 
intracellular Ca
2+
 flux (204, 205). As such, the recent discovery that MAMs are the sites where 
GM1 accumulates and influences ER-to-mitochondria Ca
2+
 flux, leading to Ca
2+
 overload and 
activation of the mitochondrial apoptotic pathway, explains the neuronal apoptosis and 
neurodegeneration that occurs in patients with GM1-gangliosidosis (203). These findings may have 
important implications for targeting checkpoints of the GM1-mediated apoptotic cascade in the 
treatment of this catastrophic disease. 
Modulation of the progression of cell death may therapeutically be very important also for the 
inhibition of tumour growth. A tumour cell must harness the Ca
2+
 signalling machinery to promote 
proliferation yet protect itself from apoptosis. Owing to their principal roles in the control of cell 
death and Ca
2+
 signalling, the ER and mitochondria are at the frontline of this battle during 
oncogenic transformation, and are thus sites where significant remodelling of Ca
2+
 signalling 
apparatus occurs to limit death-inducing Ca
2+
 signals during cancer. Specific stimulation of the Ca
2+
 
transfer between the IP3R and mitochondria could specifically destabilize Ca
2+
 homeostasis in 
cancer cells and sensitize mitochondria towards apoptosis. Treating both normal and cancer cells 
with an agent that disrupts these pathways may kill the cancer cell, owing to the loss of redundancy. 
Such novel and highly innovative strategies can provide rationale and approaches for the design and 
development of novel technologies based on ER-mitochondria Ca
2+
 transfer for the diagnosis and 
treatment of cancer. 
During my PhD Programme, we have found that the tumor suppressor promyelocytic leukemia 
protein (PML) modulates the ER-mitochondria Ca
2+
-dependent cross-talk due to its unexpected and 
fundamental role at MAMs, highlighting a new extra-nuclear PML function critical for regulation of 
cell survival. This was demonstrated to be mediated by a specific multi-protein complex, localized 
at MAMs, including PML, IP3R3, the protein phosphatase PP2a, and Akt. Our results (presented in 
section 3.2 and in Reference (206)) show that PML mediates PP2a retention in the MAMs, which 
dephosphorylates and inactivates Akt. Thus, in the absence of PML, the unopposed action of Akt at 
the ER, due to an impaired PP2a activity, leads to a hyperphosphorylation of IP3R3 and in turn a 
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reduced Ca
2+
 flux from ER to mitochondria, rendering cells resistant to apoptotic Ca
2+
-dependent 
stimuli (Figure 6). 
 
 
 
Figure 6. Representation of MAMs proteins involved in ER-mitochondria Ca
2+
 cross-talk and perturbations 
implicated in cell survival and cell death. Ca2+ release from the ER results in high-Ca2+ hot spots at the mitochondrial 
surface to allow efficient Ca2+ uptake through VDAC - which is coupled to the IP3R by the chaperone grp75 - and the 
MCU. Mitochondrial Ca2+ activates organelle metabolism and ATP synthesis but also, when in excess, triggers 
apoptosis. Apoptosis deregulation is involved in the pathogenesis of neurodegenerative diseases as well as tumors 
development. Presenelin-1 (PS1) and Presenelin-2 (PS2), two proteins that when mutated cause familial Alzheimer’s 
disease (AD), have been recently found at MAMs, and familial AD (FAD) variants of PS2 (PS2FAD) seem to increase ER 
and mitochondria interaction; this could result in mitochondrial Ca2+ overload and subsequent excessive apoptosis. In 
addition, controlled apoptosis is likely to be important to eliminate cells, thereby avoiding tumor genesis. In this 
process the tumor suppressor PML localized at ER/MAMs and plays a crucial role as it promotes IP3R-mediated Ca2+ 
transfer from ER into mitochondria. While Akt is known to suppress IP3R-channel activity by its phosphorylation, the 
recruitment of protein phosphatase PP2a via PML in a specific multi-protein complex (comprising PML, IP3R-3, PP2a, 
and Akt), dephosphorylates and inactivates Akt. This suppresses Akt-dependent phosphorylation of IP3R-3 and thus 
promotes Ca2+ release through this channel and Ca2+ transfer into the mitochondria. In cancer cells, where PML is 
often missing, IP3R3 are hyper-phosphorylated due to an impaired PP2a activity, as a result the Ca2+ flux from ER to 
mitochondria is reduced and cells become resistant to apoptosis. 
 
 
Interestingly, the 66-kDa isoform of the growth factor adapter shc (p66shc) (207), a cytosolic 
adaptor protein which is involved in the cellular response to oxidative stress, has been recently 
found also in the MAMs fraction. In particular, the level of p66Shc in MAMs fraction is age-
dependent and corresponds well to the mitochondrial ROS production which is found to increase 
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with age (208). p66shc is one of the key regulators of ROS production, mitochondrial dysfunction, 
and ageing. The mechanisms by which p66shc increases intracellular ROS levels, inducing 
apoptosis and the deleterious effects of ageing have recently been clarified by our group. Once 
imported into mitochondria, p66Shc causes alterations of organelle Ca
2+
 responses and three-
dimensional structure, thus inducing apoptosis (209). 
Finally, the functional significance of MAMs resident proteins in the regulation of ER-
mitochondrial cross-talk is further supported by the finding that several viral proteins, such as the 
human cytomegalovirus vMIA (210), as well as the p7 and NS5B proteins of hepatitis C virus 
(211), are targeted to the MAMs and exert anti- or pro-apoptotic effects, respectively. 
 
 
Figure 7. Schematic view of the interorganelle interactions and protein composition of the membranes contact sites. 
Possible contact sites between organelles are marked in dotted brown line. 
ER, endoplasmic reticulum; ER lumen, endoplasmic reticulum lumen; IMM, inner mitochondrial membrane; MAMs, 
mitochondria-associated membranes; OMM, outer mitochondrial membrane; PAMs plasma membrane associated 
membranes; PM, plasma membrane. 
The color indicates the function/role of the protein.  
Akt, the serine-threonine protein kinase Akt; ANT, adenine nucleotide translocase; Bap31, B-cell receptor-associated 
protein 31 (or endoplasmic reticulum resident cargo receptor); Calr, carleticulin; CRAC, Ca2+ release-activated 
calcium channel; Cyp D, cyclophilin D; cyt. c, cytochrome c; ERp44, endoplasmic reticulum resident protein 44; 
grp75, glucose-regulated protein 75 (or mortalin); BiP, Binding immunoglobulin Protein (or 78 kDa glucose-regulated 
protein (GRP78)); IP3R, inositol 1,4,5-triphosphate receptor; MCU, mitochondrial calcium uniporter; Mfn1/2 
mitofusin-1/2; Ora i, ORAI calcium release-activated calcium modulator; OSBP, oxysterol binding protein; p66Shc, 
66-kDa isoform of the growth factor adapter shc; PACS-2, phosphofurin acidic cluster sorting protein 2; PEMT2, 
phosphatidylethanolamine N-methyltransferase 2; PP2a, protein phosphatase 2a; PML, promyelocytic leukemia 
protein; PS1/2, presenilin-1/2; PSS-1a, phosphatidylserine synthase-1a; SERCA2b, sarco-endoplasmic reticulum 
calcium ATPase 2b; Sig-1R, Sigma-1 receptor; STIM1, stromal-interacting molecule 1; Stt4p, phosphatidylinositol-4-
kinase; t SERCA1, truncated sarco-endoplasmic reticulum Ca2+ ATPase; VDAC, voltage-dependent anion channel; ?, 
unknown protein. 
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The deeper understanding at the molecular level of the structural and functional links that are 
established at MAMs and the possibility to modulate them may in the future be of great importance 
in the treatment of many different human pathologies. 
To summarize, a schematic representation of the ER-mitochondria interactions and some of MAM 
proteins with the assigned functions is presented in figure 7. 
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2.AIMS: 
 
 
 
The communication between the ER and mitochondria is important for bioenergetics and cellular 
survival. The ER supplies Ca
2+
 directly to mitochondria via IP3Rs at close contacts between the two 
organelles referred to as MAMs. The disruption of these contact sites has profound consequences 
for cellular function, such as imbalances of intracellular Ca
2+
 signalling and disrupted apoptosis 
progression. However, the precise molecular definition of the physical and functional interaction 
between ER and mitochondria still awaits a fine clarification of the macromolecular complexes 
assembled at the interphase between the two organelles. This project propose to investigate the 
molecular aspects that control the dynamics of the organelle-organelle interaction and their 
relationship with Ca
2+
 signals and control of apoptosis. 
The Voltage-dependent anion channel (VDAC), the most abundant protein of the OMM, is in a 
crucial position in the cell where it forms an important interface between ER and mitochondria. 
VDAC has been identified at the MAMs and is deeply involved in  efficient delivery of Ca
2+
 from 
the ER to mitochondria. Strikingly, VDAC1 is a pro-apoptotic protein while VDAC2 exert a 
protective effect. Therefore we analysed the contribution of the different VDAC isoforms to global 
cellular Ca
2+
 homeostasis, in order to establish the role of this non-redundant molecular route in 
transferring Ca
2+
 signals to mitochondria in apoptosis 
Ca
2+
 signalling proteins and organelles are also emerging as additional cellular targets of oncogenes 
and tumour suppressors. The ER-to-mitochondria Ca
2+
 transfer is often remodelled or deregulated 
in tumour cells to sustain proliferation and avoid cell death. The PML and PTEN tumour 
suppressors have been demonstrated to display uncanonical and different subcellular localization as 
well as a broad and fundamental role in apoptosis. Therefore we analyzed the role of PML and 
PTEN in the control of ER-mitochondria Ca
2+
 cross-talk and in induction of apoptosis. 
In particular we took advantage from the long standing experience of our group in the analysis of 
cellular Ca
2+
 signalling, cell fractionation and use of fluorescent probes, in order to precisely 
characterize the contribution of these proteins to global cellular Ca
2+
 homeostasis and apoptosis. 
 
 
 
38 
 
3.RESULTS: 
 
 
 
3.1 VDAC1 selectively transfers apoptotic Ca
2+
 signals to mitochondria 
 
Introduction 
VDACs, the most abundant proteins of the OMM, mediate the exchange of ions and metabolites 
between the cytoplasm and mitochondria, and are key factors in many cellular processes, ranging 
from metabolism regulation to cell death. Multicellular organisms and mammals have three distinct 
VDAC genes (VDAC1, VDAC2 and VDAC3), with high sequence homology and similar structure 
(see Introduction, section 1.4).  
Besides its fundamental role as metabolite exchanger, the pleiotropic role of VDACs appears to rely 
on their ability to engage protein-protein interactions with different partners. Indeed, VDACs have 
been shown to interact with cytoskeletal elements such as actin and tubulin (212, 213), metabolic 
enzymes (90), Bcl2-family members including Bak (214), Bad (215), tBid (216) and Bcl-XL (89), 
or other channels such as ANT (217), or the IP3R (171, 203). This scenario is further complicated 
by evidence showing that VDAC contribution to cell death can be isoform and stimulus dependent. 
Given that VDAC exists in three different isoforms that share similar electrophysiological 
properties (molecular weight cutoff, voltage dependence, etc., ) (82), one would expect that all three 
isoforms exert the same effect on apoptosis, i.e. enhancing cell death by increasing mitochondrial 
Ca
2+
 uptake. Unfortunately, this simple model is contradicted by previous work: indeed, Cheng and 
colleagues demonstrate that VDAC2 is a potent anti-apoptotic protein, and proposed a molecular 
mechanism where VDAC2 prevents Bak activation by inhibiting its oligomerization and OMM 
permeabilisation (218). Thus, two different VDAC isoforms are reported to act on apoptosis in the 
opposite direction: VDAC1 acts predominantly as a pro-apoptotic protein (78, 219) whereas 
VDAC2 exerts a protective role against cell death (218). 
The notion that these different isoforms are not simply redundant but could potentially being 
involved in radical different functions is supported by some observations. First of all, the presence 
of one single archetypical mitochondrial porin in simpler organisms (such as yeasts or Neurospora 
Crassa) and several different isoforms in more complex organisms (ranging from plants to 
mammals) suggests that gene duplication and divergent evolution likely occurred, conferring 
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specific functions to different isoforms. Moreover, gene ablation of the different isoforms in mice 
lead to different phenotypes. VDAC1, VDAC3 KO, as well as VDAC1/3 DKO, are viable but with 
variable defects (KO of VDAC1 reduces respiratory capacity (81), KO of VDAC3 causes male 
sterility (220), VDAC1- and VDAC3-KO show deficits in learning behavior and synaptic plasticity 
(221) and the lack of both VDAC1 and VDAC3 causes growth retardation (220)), while the ablation 
of VDAC2 is embryonic lethal (81). In any case, apart from these clues, a serious and rigorous 
assessment of the role of the different VDAC isoforms was still missing. 
Given the relevance that mitochondrial Ca
2+
 plays in triggering apoptosis we test whether these 
differences are due to a diverse channeling capacities toward this cation in living cells. Indeed, 
mitochondrial Ca
2+
 accumulation acts as a „priming signal‟ sensitizing the organelle and promoting 
the release of caspase cofactors, both in isolated mitochondria as well as in intact cells (189, 222). 
In this context, ER-mitochondria contacts mediate the tight and efficient Ca
2+
 transmission between 
the two organelles and thus could represent a potential regulatory site for cell death signals. Here 
we investigate the role of the different VDAC isoforms in the context of cell sensitivity to apoptosis 
and their role in regulating ER-mitochondrial Ca
2+
 signals transmission, and demonstrated that 
VDAC1, by selectively interacting with the IP3Rs, is preferentially involved in the transmission of 
the low-amplitude apoptotic Ca
2+
 signals to mitochondria. 
 
 
Results 
 
Silencing of the three VDAC isoforms differentially regulate cellular sensitivity to apoptotic stimuli 
In this part of the PhD project, we aimed to correlate the Ca
2+
 channelling properties of the VDAC 
isoforms with their effects on cell death. We first downregulated the individual isoforms by RNAi 
silencing (Figure 8c). The siRNA of interest was cotransfected with a GFP reporter, and the effect 
on cell fate was evaluated by applying an apoptotic challenge (C2-ceramide or H2O2) and 
comparing the survival of transfected and non-transfected cells. In these experiments, the siRNA of 
interest was co-transfected with a GFP reporter and the percentage of GFP-positive cells was 
calculated before and after applying an apoptotic stimulus (C2-ceramide or H2O2). In mock-
transfected cells, although the total number of cells is reduced after cell death induction, the 
apparent transfection efficiency was maintained (i.e. transfected and non-transfected cells have the 
same sensitivity to the apoptotic stimulus and thus die to the same extent). However, when GFP-
positive cells are co-transfected with a construct influencing their sensitivity to apoptosis, this will 
be reflected by a change in the fraction of fluorescent cells, that is, in the „apparent‟ transfection 
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efficiency. Thus, protection from apoptosis results into an apparent increase of transfection, 
whereas a decrease reflects a higher sensitivity to apoptosis. The results of the experiment are 
shown in Figure 8. 
 
 
Figure 8. Sensitivity to apoptotic challenges 
of VDAC-silenced cells. Cells were co-
transfected with a fluorescent marker (GFP) 
and the siRNA of interest. The graph bar 
shows the change in percentage of 
fluorescent cells before the treatment with 
100 M H2O2 for 2 h ((a) control -3.75.2%; 
siRNA-hVDAC1 204.1%; siRNA-hVDAC2 -
44.46.8%; siRNA-hVDAC3 +4.73.1%) 
and 30 M C2-ceramide for 2 h ((b) control 
-45.3%; siRNA-hVDAC1 +24.35.1%; 
siRNA-hVDAC2 -50.16.8%; siRNA-
hVDAC3 +7.12.5%). (c) HeLa cells were 
transfected for 48 h with control or siRNA-
hVDAC encoding plasmid. Cells were 
harvested, total protein was extracted and 
subjected to western blotting analysis with 
antibodies anti-β-tubulin as loading control 
and anti-VDAC specific antibodies as 
indicated 
 
 
 
 
 
 
 
 
 
 
 
 
Mocktransfected cells show no difference in the percentage of fluorescent cells after H2O2 treatment 
(-3.75.2%), whereas in the same conditions VDAC1-, VDAC2- and VDAC3-silenced GFP-
positive cells were varied by 204.1%, -44.4±6.8% and 4.73.1%, respectively (Figure 8a). Similar 
results were obtained with C2-ceramide (Figure 8b). This confirms the notion that VDAC1 is pro-
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apoptotic and, among the various reported effects of VDAC2, the pro-survival role is prevailing in 
HeLa cells. Finally, VDAC3 shows no significant effect on apoptosis. 
 
All VDAC isoforms enhance mitochondrial Ca
2+
 
Considering that the enhancement of mitochondrial Ca
2+
 uptake generally correlates with increased 
sensitivity to apoptosis and that VDAC1 has been shown to be a regulator of OMM permeability to 
Ca
2+
 , we wondered whether isoform specificity could rely on different Ca
2+
 channeling properties 
of the VDACs. The individual VDAC siRNAs were thus co-transfected with a mitochondrial Ca
2+
-
probe (mtAEQmut). After aequorin reconstitution with the cofactor coelenterazine, cells were 
challenged with 100 M histamine, and luminescence was measured and converted to Ca2+, as 
described in the Materials and Methods section. VDAC1 silencing significantly reduced the 
histamine-induced [Ca
2+
]m peak (Figures 9a and c, [Ca
2+
]m peak values: control, 88.62.7 M; 
siRNA-hVDAC1, 75.63.2 M; siRNA-hVDAC2, 64.93.5 M; siRNA-hVDAC3, 693.8 M). 
Interestingly, VDAC2 and VDAC3 silencing had the same effect, if anything greater. To confirm 
this notion, we carried out overexpression experiments, and, also in this case, VDAC1 showed an 
enhancement of mitochondrial Ca
2+
 uptake, in agreement with previous data (78). The effect was 
comparable, if not smaller, than that observed upon overexpression of VDAC2 and VDAC3 
(Figures 9b and c, [Ca
2+
]m peak values: hVDAC1-EYFP, 97.73.3 M; hVDAC2-EYFP, 102.74.2 
M; hVDAC3-EYFP, 112.85.5 M). 
 
 
 
 
 
Figure 9. Effect of VDAC isoform silencing or overexpression on mitochondrial Ca
2+
 uptake. [Ca2+]m increase 
evoked by histamine stimulation in VDAC-silenced (a and c) or VDAC-overexpressing (b and c) cells ([Ca2+]m peak 
values: control, 88.62.7 M; siRNA-hVDAC1, 75.63.2 M; siRNA-hVDAC2, 64.93.5 M; siRNAhVDAC3, 693.8 
M; hVDAC1-EYFP, 97.73.3 M; hVDAC2-EYFP, 102.74.2 M; hVDAC3-EYFP, 112.85.5 M). (a and b) 
Representative traces, (c) bar graph of the average [Ca2+]m peak. The traces are representative of >12 experiments that 
gave similar results. The bar graphs are the average of all experiments performed 
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All VDACs do not affect ER Ca
2+
 content and cytosolic Ca
2+
 transients 
To rule out a confounding effect on cytosolic Ca
2+
 signaling, we measured ER and cytosolic [Ca
2+
] 
with the appropriate aequorin chimeras. Silencing or overexpression of the three VDAC isoforms 
did not alter significantly the state of filling of the ER store (Figure 10a), nor of its release kinetics 
(data not shown). Accordingly, the cytosolic [Ca
2+
] transient evoked by histamine stimulation was 
not significantly affected when any isoform were silenced (Figure 10b) or overexpressed (Figure 
10c). Finally, mtGFP imaging and mitochondrial loading with the potential sensitive dye 
tetramethylrhodamine methyl ester (TMRM) showed that the effect was not due to changes in 
mitochondrial morphology or significant reduction of mitochondrial membrane potential (data not 
shown).  
 
 
 
 
Figure 10. Effect of VDAC isoform silencing or overexpression on ER and cytosolic [Ca
2+
]. (a) Effect of the 
overexpression, or silencing, of individual VDAC isoforms on [Ca2+]er steady-state levels (control, 360.110.5 M; 
siRNA-hVDAC1, 351.910.6 M; siRNA-hVDAC2, 352.312.3 M; siRNA-hVDAC3, 346.515.1 M; hVDAC1-EYFP, 
36815.6 M; hVDAC2-EYFP, 364.514.4 M and hVDAC3-EYFP, 353.616.6 M). Transfection with the 
appropriate aequorin probe, reconstitution and [Ca2+] measurements were carried out as detailed in the methods 
section. When indicated, the cells were challenged with 100 M histamine. erAEQ transfection and [Ca2+]er 
measurements, after ER Ca2+ depletion, aequorin reconstitution and ER refilling were carried out as detailed in the 
methods section. (b and c) Representative traces of cytosolic Ca2+ transients evoked by 100 M histamine in VDAC-
silenced (b) and overexpressing (c) cells ([Ca2+]c peak values: control, 3.060.05 M; siRNA-hVDAC1, 2.850.06 M; 
siRNA-hVDAC2, 2.810.07 M; siRNA-hVDAC3, 2.980.06 M; hVDAC1-EYFP, 2.940.06 M; hVDAC2-EYFP, 
2.970.07 M and hVDAC3-EYFP, 3.080.04 M). The traces and graph bars of this figure are representatives of >12 
experiments that gave similar results 
 
 
Altogether, these data, while showing a clear effect of VDAC silencing or overexpression on 
mitochondrial Ca
2+
 handling, argue against the possibility that the pro-apoptotic effect of VDAC1 
depends on a greater Ca
2+
 conductance of this isoform. Rather, the data may suggest a preferential 
role of the VDAC2 and VDAC3 isoforms in Ca
2+
 transport (also considering their lower expression 
levels (223)), although the real significance of this observation could be hampered by differences in 
protein stability or trafficking to the OMM. 
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VDAC1 specific coupling to ER Ca
2+
 releasing channels 
The pro-apoptotic activity of VDAC1 thus appears either totally independent of Ca
2+
, or due to the 
fine tuning of Ca
2+
 signals in specialized microdomains that may be overlooked in bulk cytosolic 
measurements (34). We followed the latter possibility, based on growing evidence demonstrating 
that the mitochondria-ER crosstalk is not merely the consequence of physical neighborhood but 
relies on the existence of macromolecular complexes linking the two organelles (see Introduction, 
section 1.7). Specifically, during massive Ca
2+
 release upon maximal agonist stimulation, the 
existence of discrete signaling units could be overwhelmed and masked by the robustness of the 
response. Conversely, when an apoptotic stimulus causes a small, sustained Ca
2+
 release the 
existence of preferential channelling routes could become relevant. Based on previous data, 
showing the interaction of the IP3R with VDAC mediated by the grp75 chaperone (171), we 
investigated whether IP3Rs and grp75 preferentially interact with VDAC1, forming privileged 
signaling units. 
We first performed co-immunoprecipitation experiments using the highly expressed IP3R3 as bait. 
Strikingly, Figure 11a shows that VDAC1 is the only isoform bound to the IP3R in stringent 
conditions: no VDAC2 or VDAC 3 could be detected, also in long-term exposures. Neither actin, 
nor hexokinase-I, a known interactor of VDAC1, were co-immunoprecipitated in the assay, whereas 
the grp75 chaperone did. To confirm the specificity of the interaction, we also carried out the 
reverse experiment, by immunoprecipitating VDAC1 and revealing the presence of grp75 and 
IP3R3 in the precipitate. In these experiments, the cells were transfected with an HA-tagged 
VDAC1 fusion protein, and immunoprecipitation was carried out with anti-HA antibodies. The 
results, shown in Figure 11b, demonstrate that both IP3R3 and grp75 co-immunoprecipitate with 
VDAC1 (similarly to previous data with the IP3R1 (171), and see also Figure 12c). 
 
Apoptotic treatment enhances VDAC1 specific coupling to IP3Rs 
We then investigated whether the VDAC1-IP3Rs interaction is altered in apoptotic conditions. We 
thus performed coimmunoprecipitations in cells challenged with H2O2 using grp75 or VDAC1-HA 
as bait. VDAC1 pull-down in H2O2-treated cells resulted in a significantly greater amount of both 
grp75 and IP3R in the immunoprecipitate (Figure 12a), and the relative amount of IP3R co-
immunoprecipitating with grp75 was significantly greater in H2O2-treated cells (Figure 12b). 
Moreover, we performed co-immunoprecipitation experiments also with IP3R type 1: as shown in 
Figure 12c, similarly to IP3R3, also IP3R1 interacts with VDAC1 but not with VDAC2, and H2O2 
treatment enhance this interaction (although the effect seems weaker than with IP3R3). 
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Figure 11. Co-immunoprecipitations of VDAC1 with 
IP3R3. Co-immunoprecipitations using IP3R3 (a) and 
VDAC1-HA (b) as baits. HeLa cells were grown in 10-
cm Petri dishes until full confluence. For VDAC1-HA 
immunoprecipitation, cells were transfected 48 h 
before experiment. Cells were then detached by 
scraping, harvested and proteins were extracted in 
non-denaturing conditions as indicated in the methods 
section. After protein quantification, 700 g were 
incubated overnight at 4 °C with the 3 g of the 
indicated antibody. The immunocomplex was then 
isolated by adding protein G-coated sepharose beads 
for 2 h at 4 °C. The purified immunocomplex was then 
washed three times with lysis buffer. Indicated 
fractions were then subjected to SDS-PAGE and 
western blotting, and probed with the indicated 
antibodies 
 
 
 
 
 
 
 
 
 
 
Figure 12. Co-immunoprecipitations of VDAC1 with 
IP3R3 after H2O2 treatment. Co-immunoprecipitations 
using VDAC1-HA (a), grp75 (b) and IP3R-1 (c) as 
baits. HeLa cells were grown in 10-cm Petri dishes 
until full confluence. For VDAC1-HA 
immunoprecipitation, cells were transfected 48 h 
before experiment. Cells were then detached by 
scraping, harvested, incubated for 10 min with vehicle 
or 1 mM H2O2 and proteins were extracted in non-
denaturing conditions as indicated in the methods 
section. After protein quantification, 700 g were 
incubated overnight at 4 °C with the 3 g of the 
indicated antibody. The immunocomplex was then 
isolated by adding protein G- (for anti-HA) or A- (for 
anti-IP3R-1 and grp75) coated sepharose beads for 2 h 
at 4 °C. The purified immunocomplex was then washed 
three times with lysis buffer. Indicated fractions were 
then subjected to SDS-PAGE and western blotting, and 
probed with the indicated antibodies 
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VDAC1 selectively transfers apoptotic Ca
2+
 signals to mitochondria. 
In order to test whether the interaction of VDAC1 and IP3Rs is involved in apoptotic signaling, we 
investigated the Ca
2+
 transients evoked by apoptotic stimuli in VDAC-silenced cells. We applied an 
oxidative stress, that is, treated the cells acutely with 1 mM H2O2. As previously reported (222), the 
addition of H2O2 caused a [Ca
2+
]c increase that is much smaller and more sustained than that evoked 
by histamine (Figures 13a and b). Under those conditions, mitochondria also undergo a small 
increase (peak value <1 M). VDAC1 silencing decreased mitochondrial Ca2+ accumulation, while 
the knock-down of the other isoforms was indistinguishable from controls. We then titrated the 
histamine concentration in order to elicit a small Ca
2+
 response, comparable to that evoked by H2O2 
by applying a 0.5 M histamine challenge. Under those conditions, no difference among the 
different VDAC isoforms could be revealed (Figure 13c), thus suggesting that besides the slow 
kinetics the strengthening of the physical coupling of the IP3R and VDAC1 channels by apoptotic 
challenges may have an important role in the potentiation of mitochondrial Ca
2+
 signals and the 
induction of cell death. 
 
 
 
Figure 13. VDAC1 selectively transfers apoptotic Ca
2+
 signals to mitochondria. Representative traces (a) and 
statistics (b) of [Ca2+]m evoked by the acute administration of 1 mM H2O2 ([Ca
2+]m peak values: control, 0.6170.015 
M; siRNA-hVDAC1, 0.4690.025 M; siRNA-hVDAC2, 0.6320.016 M; siRNA-hVDAC3, 0.6440.016 M). (c) 
[Ca2+]m increases evoked by 0.5 M histamine. All other conditions as in Figure 9 
 
 
Discussion 
 
Several observations support the notion that VDAC can finely tune cellular processes in an isoform-
specific way: (i) selective genetic ablation of the three VDAC genes exhibits different phenotypes 
(224) (ii) VDAC1 and VDAC2 exert diametrically opposite effects on apoptosis (78, 218, 225) and 
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a compound acting through VDAC2, erastin, is effective in tumors harboring Ras mutations (226); 
(iii) apoptotic challenges (227) and genomic programs, such as the PGC1- pathway (De Stefani 
and Rizzuto, unpublished), differentially regulate the expression of VDAC isoforms; and (iv) the 
three isoforms are localized to different sub-domains of the OMM (228). We thus investigated in 
greater detail the molecular mechanism underlying the different role of VDAC isoforms in 
apoptosis. 
The first, obvious explanation of this diversity relied on different Ca
2+
 channelling capacities, given 
the sensitizing role of Ca
2+
 in the release of caspase activators. Our results ruled out the possibility, 
by showing relatively minor differences in Ca
2+
 channelling that cannot account for their 
differential cell death regulation. These minor differences could potentially be due to small 
variations in Ca
2+
 transport capacities. However, as in situ VDAC levels after overexpression or 
gene silencing are quite difficult to rigorously assess, this conclusion is risky. These data simply 
support the notion that all VDAC isoforms can similarly transport Ca
2+
 in living cells, and this is 
not correlated with their effect on apoptosis. 
How can we then solve the discrepancy between mitochondrial Ca
2+
 transport and apoptosis 
regulation? An obvious conclusion is the denial (or, at least the reconsideration) of the classic 
paradigm linking mitochondrial Ca
2+
 to apoptosis. However, this notion is now supported by broad 
evidence showing that mitochondrial Ca
2+
 loading favors cell death and signalling molecules 
reducing or increasing Ca
2+
 signals protect from or enhance apoptosis, respectively (135). Ca
2+
 in 
mitochondria, however, is an intrinsically pleiotropic signal, and the final outcome varies widely 
depending on both the nature of the stimulus (and hence the „Ca2+ signature‟) and concomitant 
signalling pathways. Indeed, while physiological stimuli cause the rapid release of Ca
2+
 from 
internal stores, and thus a large and transient mitochondrial Ca
2+
 uptake, cell death signals have 
been shown to induce only a modest (even if sustained) [Ca
2+
]m increase (222). This latter event has 
been proposed to represent a sort of priming signal that conditions and sensitizes mitochondria to 
otherwise non-lethal stimuli. In this context, the local coupling between ER and mitochondrial Ca
2+
 
channels becomes critically relevant: small Ca
2+
 microdomains elicited by apoptotic stimuli such as 
C2-ceramide strongly relies on the existence of a preferential route transmitting the signal from the 
ER to the mitochondrion; on the other side, during physiological signals large Ca
2+
 microdomains 
are generated and this fine channel coupling could be potentially overwhelmed by the vigorous ER 
Ca
2+
 release. On the ER side, the notion that the accurate discrimination of Ca
2+
 signals mediating 
diverse effects relies on highly specialized molecular determinants was associated to the 
observation that the selective knockdown of IP3R3 impairs cell death signals transmission whereas 
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the silencing of the other two isoforms had almost no effect (139, 140). On the mitochondrial side, 
we wondered whether a similar selectivity could be associated to the mitochondrial channel 
repertoire at ER-mitochondria contact sites. The results clearly confirmed this possibility, by 
demonstrating that VDAC1 is preferentially involved in the transfer of apoptotic stimuli (such as 
those induced by H2O2) rather than physiological responses to agonists. Strikingly, our co-
immunoprecipitation studies showed that IP3R selectively interacts with VDAC1, providing a 
molecular route for the higher sensitivity of the Ca
2+
 transfers. Moreover, this selective interaction 
appears not static but finely tuned by cellular conditions, as demonstrated by the fact that H2O2 
strengthens the coupling between the ER and mitochondrial Ca
2+
 channels, and by the selective 
involvement of VDAC1 in the transmission of apoptotic stimuli. 
Overall, these data reveal a complex molecular organization underlying VDAC Ca
2+
 channelling 
properties, and allowing VDAC1 to exert its pro-apoptotic activity. The emerging picture reveals 
that VDACs represent a fundamental factor in mitochondria physiology, with similar channelling 
properties shared among its different variants, but also mediating diverse effects through isoform-
specific protein-protein interactions and the assembly of highly specialized, higher-order protein 
complexes. This view accounts for most of experimental data available and finally reconciles 
apparently contrasting evidence, allowing a deeper insight on mitochondrial regulation of cell life 
and death. 
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3.2 PML regulates apoptosis at endoplasmic reticulum by modulating calcium 
release 
 
Introduction 
The promyelocytic leukemia (PML) protein is a tumor suppressor frequently lost or aberrant in 
hematopoietic malignancies and human solid tumors (229, 230). Its gene was originally identified at 
the break point of the t(15;17) chromosomal translocation of acute promyelocytic leukemia (APL), 
a distinct subtype of acute myeloid leukemia. As a consequence of this translocation, PML fuses to 
the retinoic acid (RA) receptor alpha (RAR) gene. Two fusion genes are generated encoding 
PML-RAR and RAR-PML fusion proteins, which coexist in the leukemic cells, blocking 
heamatopoietic differentiation. PML has, therefore, become the object of intense research on the 
basis of this premise. Since then, PML has been shown to regulate diverse cellular functions, such 
as transcriptional regulation, DNA-damage response, sumoylation process, cellular senescence, 
neoangiogenesis, and apoptosis (231). 
PML belongs to a large family of proteins harboring a tripartite structure that contains a zinc-finger 
called the RING motif (R) located N-terminally followed by two additional zincfingers motifs (B-
boxes; B) and an -helical coiled-coil domain (CC), collectively referred to as the RBCC domain. 
The RBCC domain mediates protein-protein interactions and is responsible for PML 
multimerization and the formation of macromolecular complexes. The C-terminal region of PML is 
less structured and varies between PML isoforms. Alternative splicing of C-terminal exons is 
responsible for the existence of at least seven PML isoforms characterized by different C-terminal 
regions and functional specificity (232). 
PML is typically concentrated in subnuclear macromolecular structures termed PML-nuclear bodies 
(PML-NBs), of which PML is the essential component. PML-NBs have a diameter of 0.2-1 m and 
the shape of a doughnut. PML-NBs are multiprotein dynamic structures that undergo significant 
changes in number, size, and position, particularly in response to cellular stress (233). They 
critically depend on PML to be correctly assembled (234). PML functionally interacts with a large 
number of proteins within PML-NBs. Some are in direct physical contact with PML, while others 
are not (235). PML SUMOylation and noncovalent binding of PML to SUMOylated PML through 
the SUMO-binding motif constitutes the nucleation event for subsequent recruitment of 
SUMOylated proteins and/or proteins containing SUMO-binding motifs to the PML-NBs (234). In 
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the APL blasts, PML-RAR associates physically with PML and causes its delocalization into 
microspeckled nuclear structures with consequent disruption of the PML-NBs (236). 
Pml null mice and cells are protected from multiple and diverse apoptotic stimuli (237). A possible 
explanation for why Pml null cells are resistant to many apoptotic stimuli can be ascribed to the fact 
that PML can act as a pleiotropic factor in the functional regulation of several pro- and antiapoptotic 
pathways. Indeed, PML is functioning as part of a complex tumour-suppressive network. For 
instance, it is well established that PML is an important factor in the regulation of both p53-
dependent and -independent apoptotic pathways (238). Moreover, PML can act as a suppressor of 
other major oncogenic pathways, such as the PI3K/Akt pathway, through its ability to interact with 
the protein phosphatase 2a (PP2a) and inhibit the nuclear function of Akt, thus leading to 
suppression of its prosurvival and promitogenic functions (239). Finally, PML regulates the 
function of PTEN (phosphatase and tensin homolog deleted on chromosome 10), which is the main 
suppressor of the PI3K pathway (see Results, section 3.3). PML co-ordinate PTEN subcellular 
nuclear localization: this occurs through inhibition of PTEN de-ubiquitination by HAUSP 
(herpesvirus-associated ubiquitin-specific protease) and its nuclear retention. As a consequence, 
both in APL blasts and in PML-loss conditions, PTEN is excluded from the nucleus (240, 241). 
Despite PML protein has been recognized as a critical and essential regulator of multiple apoptotic 
response, no unified mechanism appeared to explain the global resistance of Pml null cells to 
apoptosis. How PML would exert such broad and fundamental role in apoptosis remained for long 
time a mystery. Interestingly, many, if not all, PML isoforms have shown both cytoplasmic and 
nuclear localization (242, 243). 
Therefore in this part of the PhD project, we aimed to understand how PML could regulate such 
broadly diverse apoptotic responses through its extranuclear localization. In particular, we analyzed 
PML intracellular localization by cell fractionation and found that extranuclear PML was 
specifically enriched at the ER and MAMs. So, we investigated the role of PML at MAMs in the 
control of the functional cross-talk between ER and mitochondria. We found PML in complexes of 
large molecular size with the IP3R, Akt and PP2a, and demonstrated that PML is essential for Akt- 
and PP2a-dependent modulation of IP3R phosphorylation and in turn for IP3R-mediated Ca
2+
 
release from the ER to the mitochondria. Our findings provide a mechanistic explanation for the 
elusive mechanism whereby the PML tumour suppressor exerts its essential role in apoptosis 
triggered by Ca
2+
-dependent stimuli and identify a novel unexplored pharmacological target for the 
modulation of Ca
2+
 signals and cell death. 
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Results 
 
PML localizes at ER and MAMs regions and mediates Ca
2+
-dependent apoptotic cell death 
We fractionated homogenates of primary mouse embryonic fibroblasts (MEFs) by 
ultracentrifugation, focusing on the mitochondria, ER and MAMs, the structures that contain sites 
where the ER contacts mitochondria. All fraction markers were enriched in their respective 
compartments (we used β-tubulin as a general cytosolic marker, IP3R as ER marker, VDAC as 
mitochondrial marker, and PCNA as nuclear marker); moreover, the close apposition between ER 
and mitochondrial membranes at MAMs explained the presence of both VDAC and IP3R in these 
microdomains (139, 171). PML localized both to the nucleus and the cytosol and appeared to 
localize also to the ER, MAM, and crude mitochondrial fractions but not to “pure” mitochondrial 
fraction free of ER and nuclear markers (Figure 14A). These results were confirmed by 
immunogold labeling of ultrathin cryosections showing that PML associates with the surface of the 
ER (Figure 14B, a and b) and in the proximity of the mitochondrial membrane at contact sites 
between the ER and mitochondria (Figure 14B, d to g). 
In view of the localization of PML at the ER and MAM, we investigated its requirement in 
apoptosis induced by ER stress (169). Matched wild-type (Pml
+/+
) and Pml
−/−
 MEFs were treated 
with ER stress inducers: H2O2 and menadione (MEN), two oxidizing agents that induce ER Ca
2+
 
release; tunicamycin (TN) or an inhibitor of protein N-glycosylation; and thapsigargin (TG), an 
inhibitor of the SERCA. After 12 hours of treatment, the percentage of apoptotic cells in Pml
−/−
 
MEFs was much lower than that observed in Pml
+/+
 MEFs under all treatment conditions (Figure 
14C). 
 
PML absence induces a smaller release of Ca
2+
 from ER, leading to reduced mitochondrial Ca
2+
 
uptake after agonist or apoptotic stimulation  
MAMs are specialized domains selectively enriched in critical Ca
2+
 signaling elements, which 
mediate Ca
2+
 transfer between ER and mitochondria, such as the IP3R (see Introduction, section 
1.7). Ca
2+
 signaling has a major role in the regulation of cell death. Release of the ER Ca
2+
 pool 
through the IP3R3 appears to induce a sensitization of cells to apoptotic stimuli (see Introduction, 
section 1.6). 
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Figure 14. Identification of PML at ER and MAM regions and Ca
2+
-mediated PML-dependent cell death. (A) 
Detection of PML by immunoblotting in Pml+/+ MEFs fractionation. IP3R, tubulin, proliferating cell nuclear antigen 
(PCNA), VDAC are used as markers. H: homogenate; Mc: crude mitochondria; Mp: pure mitochondria; ER; MAM; C: 
cytosol; N: nucleus. (B) Immunogold labeling of PML near the rough ER (r), mitochondria (m), and MAM 
(arrowheads) in Pml+/+ MEFs. Gold particles (15 nm) are mostly associated with the surface of the ER (7.07 gold 
particles/m2) and more occasionally with mitochondrial membranes (3.08 gold particles/m2) (a and b). Specificity of 
the antibodies is demonstrated by labelling of nuclear bodies (n) (c). Morphologically identified MAM often 
demonstrated labeling at contacts between ER and mitochondria [(d) to (g), and arrowheads in insets therein]. Insets 
correspond to boxed areas. Bar: (a) 360 nm; (b) 340 nm; (c) 370 nm; (d) 188 nm, inset 120 nm; (e) 260 nm, inset 190 
nm; (f) 340 nm, inset 180 nm; (g) 280 nm, inset 210 nm. (C) Apoptosis induced by 1 mM H2O2, 15 M menadione 
(MEN), 6 M tunicamycin (TN), 2 M thapsigargin (TG), or 50 M etoposide (ETO) in Pml+/+ or Pml−/− MEFs treated 
for 12 hours. Data represent the mean SD of five independent experiments. 
 
 
To investigate the role of PML in Ca
2+
 homeostasis, we used recombinant Ca
2+
-sensitive 
bioluminescent protein aequorin (244). In Pml
+/+
 MEFs, the [Ca
2+
] in the lumen of the ER ([Ca
2+
]er) 
at steady state was 450 M, whereas in Pml−/− MEFs it was lower. When the cells were stimulated 
with ATP, the P2Y receptor agonist that causes release of Ca
2+
 from the ER, the decreases in the 
[Ca
2+
]er observed in Pml
+/+
 MEFs in quantitative and kinetic terms were larger and faster than in 
Pml
−/−
 MEFs, reflecting a more rapid flow of Ca
2+
 through the IP3R (Figure 15A). In turn, the 
[Ca
2+
] increases evoked by stimulation with ATP in the cytosol ([Ca
2+
]c) and mitochondria 
([Ca
2+
]m) were smaller in Pml
−/−
 than in Pml
+/+
 MEFs (Figure 15, B and C). 
52 
 
 
 
Figure 15. Intracellular Ca
2+
 homeostasis in Pml
+/+
 and Pml
−/−
 MEFs. (A to C) ER (A), cytosolic (B), and 
mitochondrial (C) Ca2+ homeostasis measurements with aequorins. Where indicated, cells were treated with 100 M 
ATP. Pml+/+: [Ca2+]er peak 448  32 M; [Ca
2+]c peak 3.3  0.16 M; [Ca
2+]m peak 138  14 M. Pml
−/−: [Ca2+]er 
peak 386  42 M; [Ca2+]c peak 2.65  0.23 M; [Ca
2+]m peak 78  10 M. n = 15 samples from five independent 
experiments, P < 0.01. (D) MEFs loaded with calcium-sensitive fluorescent dye Fura-2/AM were stimulated with 
menadione (MEN) or 
H2O2. The kinetic behaviour of the [Ca
2+]c response is presented as the ratio of fluorescence at 340 nm/380 nm. The 
traces are representative of at least 10 single-cell responses from three independent experiments. (E) Analysis of 
[Ca2+]m during oxidative stress. Where indicated, cells were stimulated with 30 M MEN or 2 mM H2O2. n = 10 
samples from three independent experiments. 
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We then investigated whether the absence of Pml could alter the increases in [Ca
2+
]c and [Ca
2+
]m 
induced by apoptotic stimuli. In Pml
−/−
 MEFs, the increases in [Ca
2+
]c and Ca
2+
]m, evoked by the 
oxidative apoptotic stimuli, such as MEN and H2O2 that trigger both a progressive release of Ca
2+
 
from the ER and an activation of the capacitative Ca
2+
 influx (142), were smaller as mentioned 
above (Figure 15, D and E). 
 
The erPML chimera rescues Ca
2+
 homeostasis after physiological and apoptotic stimuli in Pml
−/−
 
MEFs 
To determine whether the effects of PML on regulation of Ca
2+
 homeostasis depend on its 
localization to the ER and MAMs, we generated a chimeric protein containing the entire PML 
protein that was targeted to the outer surface of the ER (245). 
This chimera, designated erPML, localized to the ER and MAMs in Pml
−/−
 MEFs, as revealed by 
immunocytochemical staining (Figure 16A). The introduction of erPML in Pml
−/−
 MEFs restored 
Ca
2+
 signals evoked by either agonist (Figure 16B) or apoptotic stimuli (MEN or H2O2) (Figure 
16C) to values comparable to those in Pml
+/+
 MEFs (Figure 15, C and D). 
This effect was associated with a re-established sensitivity to apoptosis induced by ER stress but did 
not restore the sensitivity to etoposide (ETO) (Figure 16D), a DNA-damaging agent that triggers 
apoptotic death by a Ca
2+
-independent process. 
Overall, these experiments indicate that the absence of Pml causes a reduction in the amplitude of 
Ca
2+
 signals induced by ATP, other agents, or apoptotic stimuli, and that forcing PML to the ER 
rescues these defects. A PML protein targeted to the nucleus restored the formation of NBs, but did 
not restore the Ca
2+
 responses and the sensitivity to ER stress-dependent cell death, although it 
restored response to other apoptotic stimuli such as ETO (data not shown). 
 
PML is essential for Akt- and PP2a-dependent modulation of IP3R phosphorylation and in turn for 
IP3R-mediated Ca
2+
 release from ER 
To investigate the mechanism underlying these activities of PML, we tested whether PML could 
functionally and physically interact with the IP3R3. Immunoprecipitation of IP3R3 led to the co-
precipitation of PML (Figure 17A) and vice versa (data not shown). Amounts of phosphorylated-
IP3R3 (p-IP3R3) were higher in Pml
−/−
 than in Pml
+/+
 MEFs (Figure 17A). 
Reduced cellular sensitivity to apoptotic stimuli was observed in cells with high activity of the 
protein kinase Akt, as a result of diminished Ca
2+
 flux from the ER through the IP3R (146, 147). 
The amount of phosphorylated Akt (pAkt) (that is, the active form of Akt) co-precipitated with  
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Figure 16. erPML chimera reestablishes the [Ca
2+
]m and apoptotic responses in Pml
−/−
 MEFs. (A) Schematic map of 
the erPML chimera and immunofluorescence image, stained with the antibody to PML, of Pml−/− MEFs expressing 
erPML. (B) erPML re-establishes the agonist-dependent [Ca2+]m response in Pml
−/− MEFs ([Ca2+]m peak 135  12 M) 
to values comparable to those of Pml+/+ MEFs. (C) Pml−/− and Pml−/− MEFs expressing erPML previously incubated 
with Fura-2/AM were stimulated with menadione (MEN) or H2O2. The kinetic behaviour of the [Ca
2+]c response is 
presented as the ratio of fluorescence at 340 nm/380 nm. The traces are representative of at least 10 single-cell 
responses from three independent experiments. (D) Representative microscopic fields of Pml−/− MEFs and Pml−/− 
expressing erPML before and after treatment with 1 mM H2O2, 15 M MEN, or 50 M etoposide (ETO) for 16 hours. 
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IP3R3 (Figure 17A) was higher in Pml
−/−
 than in Pml
+/+
 MEFs. Dephosphorylation of Akt at the 
MAM might occur through PML-mediated recruitment of the phosphatase PP2a. Indeed, PML 
interacts with PP2a in PML-NBs (239). Further, the amount of PP2a coprecipitated with IP3R3 
(Figure 17A) was diminished in Pml
−/−
 MEFs (Figure 17A). Thus, in the absence of Pml, reduced 
Ca
2+
 release could be caused by increased phosphorylation and activation of Akt at the ER due to an 
impaired PP2a activity, which in turn impair Ca
2+
 flux through the IP3R because of its 
hyperphosphorylated state. 
We also demonstrated the localization of all these proteins at the ER and MAM through 
immunocytochemical staining and subfractionation (Figure 17, B and C). 
We further investigated the correlation among PML, Akt, and PP2a at the ER and the regulation of 
the IP3R by a selective inhibition of either Akt or PP2a. Pretreatment of cells with okadaic acid 
(OA, a PP2a inhibitor) caused a reduction in [Ca
2+
]m responses to ATP stimulation and a reduced 
H2O2- or MEN-induced death in Pml
+/+
 MEFs (92  21 M vs 128  33 M in control cells, 
p<0.01) and in Pml
−/−
 MEFs expressing erPML (102  13 M vs. 135  17 M in control cells, 
p<0.05), but not in Pml
−/−
MEFs (73  22 M vs 78  14 M in control cells) (Figure 17, D and E), 
in which PP2a activity is impaired. LY294002 (an inhibitor of Akt) had no effect on the agonist-
dependent [Ca
2+
]m transients and on apoptosis in Pml
+/+
 (126  16 M vs 128  33 M in control 
cells) or Pml
−/−
 MEFs expressing erPML (124  13 M vs 132  18 M in control cells), whereas it 
increased agonist dependent [Ca
2+
]m responses and restored sensitivity to H2O2 or MEN (Figure 17, 
D and E) in Pml
−/−
 MEFs (112  15 M vs 78  14 M in control cells, p<0.01) (in which high 
levels of pAkt are observed; Figure 17A).  
 
 
Discussion 
 
The PML tumor suppressor is a critical and essential regulator of multiple apoptotic responses. 
While the reported role of PML in the modulation of p53 transcription could explain some of its 
pro-apoptotic functions, it failed to reconcile the fundamental role played by PML in the 
transcription-independent early apoptotic response. 
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Figure 17. Modulation of [Ca
2+
]m and apoptotic responses by PML through Akt- and PP2a-dependent 
phosphorylation of IP3R3. (A) Coimmunoprecipitation of IP3R3 with PML, Akt, and PP2a in Pml+/+ MEFs. In the 
same blot, the levels of p-IP3R3 and pAkt are shown. (B) Localization of PML (green) and PP2a (red) at ER and MAM 
sites in Pml+/+ MEFs analyzed by immunofluorescence. FACL was used as MAM marker. (C) Pml+/+ MEFs subcellular 
fractionation and identification of PP2a and Akt at ER and MAM fractions by immunoblot. (D) Effects of okadaic acid 
(OA, 1 M for 1 hour) and LY294002 (5 M for 30 min) on agonist-dependent [Ca2+]m responses in Pml
+/+, Pml−/−, 
and Pml−/− MEFs expressing erPML. [Ca2+]m is represented as a percentage of the peak value of control cells. For all 
these experiments n  15 of at least five independent experiments. (E) Quantification of cell survival of Pml+/+, Pml−/−, 
and Pml−/− MEFs expressing erPML, control (CTR, untreated) and treated first with OA (1 M for 1 hour) or 
LY294002 (5 M for 30 min) and then H2O2 or menadione (MEN) for 16 hours. The data show the percentage of living 
cells in the whole-cell population negative for annexin-V-fluorescein isothiocyanate and propidium iodide staining, 
analyzed by flow cytometry. Data show the means SD from three independent experiments. 
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Here we elucidate, at list in part, the molecular basis for such a diverse proapoptotic role. By 
ultracentrifugation, immunogold labeling, and immunofluorescence, we revealed that extranuclear 
PML is specifically enriched at ER and at the MAMs, signaling domains involved in ER-to-
mitochondria Ca
2+
 transport and in induction of apoptosis, suggesting that PML might have 
additional and yet unidentified functions independent from the PML-NB. 
The most important molecular component of the Ca
2+
 handling machinery of the ER is represented 
by the IP3Rs. IP3Rs are ligand-gated channels that serve to discharge Ca
2+
 from ER stores in 
response to agonist stimulation. However, being directly responsible for mitochondrial Ca
2+
 
overload, the release of Ca
2+
 from ER stores by IP3Rs is linked to multiple models of apoptosis. 
Recent data showed that IP3R3, localized in the MAMs, has a selective role in the induction of 
apoptosis by preferentially transmitting apoptotic Ca
2+
 signals to mitochondria. Accordingly, 
siRNA silencing of IP3R3 blocked apoptosis (246) and KO of IP3R3 significantly decreased 
agonist induced mitochondrial Ca
2+
 uptake (138). IP3Rs possess consensus sequences for 
phosphorylation by numerous kinases, including Akt, which is constitutively active in some cancer 
cells. In turn, the hyper-phosphorylation of IP3Rs by Akt inhibits ER Ca
2+
 release and reduces 
significantly cellular sensitivity to Ca
2+
-mediated pro-apoptotic stimulation (146, 147). 
We found Pml to physically interact with IP3R3, modulating its phosphorylation state by 
controlling the activity of Akt through the recruitment of the PP2a phosphatase at the ER/MAMs. In 
so doing, PML is able to regulate Ca
2+
 mobilization into the mitochondrion, which then triggers the 
cell death program. Conversely, in the absence of PML, PP2a does not accumulate in the complexes 
with IP3R and Akt, and this results in an accumulation of activated Akt (phospho-Akt). Once 
activated Akt can hyper-phosphorylate IP3R thus inhibiting the ER Ca
2+
 release towards the 
mitochondria. This was demonstrated to be mediated by a specific multi-protein complex, localized 
at ER/MAMs contact sites, including PML, IP3R3, the protein phosphatase PP2a, and Akt. In 
particular, PML appeared to be essential for the binding of PP2a to the IP3R3, hence favoring 
IP3R3 de-phosphorylation (Figure 18). 
Strikingly, the final outcome of a PML functional loss at the cellular level is similar to the one 
observed in cells overexpressing Bcl-2 or lacking of Bax/Bak (albeit through a completely different 
molecular mechanism): a reduced mitochondrial Ca
2+
 overload upon pro-apoptotic stimuli that 
dramatically blunts the apoptotic response. 
Our data highlight an extranuclear, transcriptionindependent function of PML that regulates cell 
survival through changes in Ca
2+
 signaling in the ER, cytosol, and mitochondria. This effect appears 
to be specific to Ca
2+
-mediated apoptotic stimuli because alteration in Pml did not influence cell 
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death in cells treated with ETO, which activates the apoptotic pathway in a way largely independent 
of Ca
2+
. 
 
 
 
Figure 18. Schematic model of PML effects on Ca
2+
 homeostasis. PML localized at the ER and MAM, to the outer 
surface of the ER, interacts with IP3R3, Akt and PP2a. This interaction is fundamental for the modulation of IP3R3-
phosphorylation and in turn for IP3R dependent Ca2+ release 
 
This mechanism may explain how PML can so broadly regulate the early (and transcription 
independent) apoptotic response. This new apoptogenic mechanism, which appears to operate in 
parallel to those regulated at other sites such as the PML-NBs, demonstrates that the role of PML in 
apoptosis is broader than previously believed inasmuch as it does modulate apoptosis both in the 
nucleus as well as at the MAMs. Our findings may have implications in tumorigenesis where the 
function of PML is frequently lost, or in other pathophysiological conditions where PML is 
accumulated such as cell stress, or infection with viral or bacterial pathogens. 
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3.3 PTEN localization at the ER and MAMs regulates calcium signalling and 
apoptosis 
 
Introduction 
PTEN (phosphatase and tensin homolog deleted on chromosome 10) is among the most commonly 
lost or mutated tumour suppressors in human cancers (247, 248). PTEN acts as a haploinsufficient 
tumour suppressor, with somatic alterations of at least one allele frequently observed in glioma, 
breast, colon, lung and prostate tumours, whereas its complete loss occurs at highest frequency in 
glioblastoma and endometrial carcinomas, and is generally correlated with advanced cancer and 
metastases (249). Moreover, germline mutations of PTEN have been found in cancer-susceptibility 
syndromes (250). 
PTEN is a phosphatase that has both a lipid (251) and a dual-specificity protein phosphatase activity 
(252). It dephosphorylates the plasma membrane lipid phosphatidylinositol 3,4,5-trisphosphate 
(PIP3) to generate phosphatidylinositol 4,5-bisphosphate (PIP2), thereby directly antagonizing the 
phosphatidylinositol 3-kinase (PI3K)-Akt pathway that is crucial for maintaining tissue homeostasis 
(253, 254). Loss of PTEN leads to elevated levels of PIP3 and consequent Akt hyperactivation, 
which promotes cell growth, proliferation, survival and other cellular processes (255, 256). 
Although the tumour-suppressive function of PTEN is mostly dependent on its PIP3 phosphatase 
activity, it has now been firmly established that PTEN also possesses additional novel biological 
functions that are independent of its lipid phosphatase activity (257-260). PTEN exerts such 
functions by its protein phosphatase activity and proposed non-enzymatic mechanisms, such as 
interaction with other proteins (261, 262). Recent advances have also proved that the cellular 
localization of PTEN plays a central role in its regulation (263). Several studies clearly demonstrate 
that nuclear PTEN has important tumour-suppressive functions (239, 264-266). Furthermore, PTEN 
has been found in mitochondria, in hippocampal neurons undergoing apoptosis (267) and in hearts 
exposed to ischemia-reperfusion (268), and has been proposed to be a crucial mediator of 
mitochondria-dependent apoptosis under certain circumstances.  
Mitochondria and the ER have emerged as cellular targets of oncogenes and tumour suppressors, as 
they are crucial nodes where significant remodelling of Ca
2+
 signalling occurs in tumour cells to 
sustain proliferation and avoid cell death (see Introduction, section 1.6). Indeed, despite controlling 
many processes essential for life, the ER-mitochondrial Ca
2+
 transmission can be a potent death-
inducing signal, since the enhancement of mitochondrial Ca
2+
-uptake generally correlates with 
increased sensitivity to apoptosis. The ER supplies Ca
2+
 directly to mitochondria via IP3Rs at close 
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contacts between the two organelles, referred to as MAMs. Ca
2+
-handling proteins of both 
organelles are highly compartmentalized at MAMs, providing a direct and proper mitochondrial 
Ca
2+
 signalling. Recently, numerous other proteins, including those involved in the pathogenesis of 
different disorders, have been characterized at MAMs, underling their importance for signalling cell 
fate choices (see Introduction, section 1.7). 
In this part of the PhD project, we identify a novel intracellular localization of PTEN at ER and 
MAMs. We evaluate the effect of PTEN silencing, overexpression, and ER-targeting, in regulating 
ER-mitochondrial Ca
2+
 signal transmission and in the induction of apoptosis. Taken together, the 
present data demonstrate that ER-localized PTEN is specifically involved in increasing both Ca
2+
 
transfer from the ER to mitochondria and cell sensitivity to Ca
2+
-mediated apoptosis, suggesting an 
additional mechanism of action of this important tumour suppressor. 
 
 
Results 
 
PTEN is localized in different intracellular compartments including ER and MAMs 
Besides the best-known cytoplasmic and nuclear pools, it has been reported that PTEN can 
accumulate in mitochondria. To further analyze the intracellular localization of PTEN, in particular 
its presence in the ER and MAMs, we performed detailed subcellular fractionation in HEK-293. 
We isolated crude mitochondria, nuclei and a cytosolic fraction containing lysosomes and 
microsomes. Subsequent ultracentrifugation of the cytosolic fraction results in the separation of ER 
and cytosol, whereas the crude mitochondria preparation were further fractionated on a Percoll 
gradient to obtain purified mitochondria and MAMs. We evaluated total homogenate, cytosol, ER 
and MAMs fractions by immunoblot analyses (Figure 19) using β-tubulin as a general cytosolic 
marker, IP3R3 as ER marker, FACL4 as MAMs marker, VDAC as mitochondrial marker, and 
lamin B1 as nuclear marker (to exclude nuclear contamination during fractionation); all markers 
were enriched in their respective compartments. Using this protocol, PTEN was found enriched in 
the cytosol, as expected, but we also revealed its presence in the ER and MAMs fractions. We also 
confirmed the previously described localization of Akt, the major downstream target of PTEN, at 
ER and MAMs in HEK-293 cells (206). The same results were obtained by subcellular fractionation 
of primary MEFs (Figure 20). Localization of PTEN in the ER was also verified by 
immunocytochemical staining (Figure 22a, A-A‟‟). 
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Figure 19. Identification of PTEN in ER and MAMs 
subcellular fractions. HEK-293 cells were fractionated 
into cytosol, ER and MAMs, and protein components of 
subcellular fractions were subjected to 
immunoblotting. The presence of PTEN was shown by 
using a specific monoclonal antibody. Marker proteins 
indicate ER (IP3R3), MAMs (FACL4), cytosol (β-
tubulin), mitochondria (panVDAC) and nucleus (lamin 
B1). VDAC and IP3R3 were both present in the MAMs, 
whereas all fractions were free of nuclear 
contamination. Akt presence was also verified in all 
fractions. H: homogenate; C: cytosol; ER; MAMs. 
Figure 20. Identification of PTEN in the ER and 
MAMs upon MEFs fractionation. Marker proteins 
indicate ER (IP3R3), MAMs (FACL4), cytosol (β-
tubulin), mitochondria (panVDAC) and nucleus (lamin 
B1). Akt presence was also confirmed in all fractions. 
H: homogenate; C: cytosol; ER; MAMs 
 
 
We thus demonstrate that although PTEN is mainly localised in the cytosol, the nucleus and, in a 
smaller proportion, in mitochondria (our nuclear and mitochondrial fractions contained PTEN as 
well, data not shown), a significant amount of PTEN is present in the ER and MAMs. 
 
PTEN silencing reduces ER Ca
2+
 release, thus impairing cytosolic and mitochondrial Ca
2+
 
transients elicited by agonist stimulation 
In view of the localization of PTEN at the ER and MAMs, we investigated whether it plays a role in 
regulating Ca
2+
 signalling between the ER and mitochondria. We analyzed intracellular Ca
2+
 
homeostasis after downregulation of PTEN expression by RNA interference (RNAi) silencing. Two 
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different small interfering RNAs (siRNAs), 
siRNA-PTEN(1049) and siRNA-PTEN(219), 
were generated and tested for specific 
silencing efficiency and ability to increase the 
levels of activated, Ser473-phosphorylated 
Akt (pAkt
Ser473
) (Figure 21a). 
Ca
2+
 measurements were then carried out in 
HEK-293 cells co-transfected with the PTEN 
siRNAs and specific organelle-targeted 
aequorin probes (244). Cells were stimulated 
with ATP, the P2Y receptor agonist that 
induces the generation of IP3, thus activating 
the IP3R channels and causing Ca
2+
 release 
from ER stores.  
 
Figure 21. Effect of PTEN silencing on intracellular 
Ca
2+
 homeostasis. (a) HEK-293 cells were transfected 
with siRNAs-PTEN encoding plasmid or mock 
transfected with empty vector (pSUPER) in control 
cells. Immunoblotting of total cell lysates shows that 
transfection with PTEN siRNAs effectively decreased 
PTEN protein levels and increased pAktS473 levels, 
reflecting an effective Akt activation without altering 
its expression. Numbers indicate densitometrically 
determined protein levels relative to actin for PTEN 
and to total Akt for pAktSer473. The traces (b, d, f, h) 
show representative [Ca2+] measurements performed 
in PTEN-silenced HEK-293 cells co-transfected with 
the appropriate aequorin (AEQ) chimera (erAEQmut, 
cytAEQ and mtAEQ for monitoring the ER, cytosol and 
mitochondria, respectively). Where indicated, cells 
were challenged with 100 M ATP to induce Ca2+ 
release from the ER. The bar graphs (c, e, g) are the 
average of all experiments performed. (b) [Ca2+]er 
steady-state levels. (c) Mean rate of Ca2+ release. (d) 
ER Ca2+ release kinetics. (e) Average [Ca2+]c peak. (f) 
Cytosolic Ca2+ transients. (g) Average [Ca2+]m peak. 
(h) Mitochondrial Ca2+ transients. Transfection, 
aequorin reconstitution and measurements of 
luminescence were carried out and calibrated into 
[Ca2+] values as described in the Materials and 
Methods section. The traces and bar graphs  of this 
figure are representatives of  10 samples from at least 
three independent experiments that yielded similar 
results. 
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The effect of PTEN silencing on ER Ca
2+
 handling was first investigated (see Materials and 
Methods section for details). Silencing of PTEN did not alter significantly the Ca
2+
 loading kinetics, 
nor the steady state [Ca
2+
] of the ER lumen ([Ca
2+
]er) (Figure 21b, [Ca
2+
]er: pSUPER, 321.1  27.30 
M; siRNA-PTEN(1049), 286.7  23.17 M; siRNA-PTEN(219) 293.9  27.59 M; n  10). 
However, upon ATP stimulation, Ca
2+
 release kinetics from the ER were slower in PTEN-silenced 
cells (Figures 21c and d, Vmax: pSUPER, 28.68  2.12 M/s; siRNA-PTEN(1049) 21.89  1.97 
M/s; siRNA-PTEN(219) 21.25  2.69 M/s; n  10, p < 0.05). Accordingly, ATP elicited a 
significantly smaller transient [Ca
2+
] rise in the cytosol ([Ca
2+
]c) and in the mitochondrial matrix 
([Ca
2+
]m) (Figures 21e and f, [Ca
2+
]c peak values: pSUPER, 1.29  0.04 M; siRNA-PTEN(1049) 
1.15  0.04 M; siRNA-PTEN(219) 1.16  0.03 M; n  30, p < 0.05; figures 21g and h, [Ca2+]m 
peak values: pSUPER, 2.17  0.14 M; siRNA-PTEN(1049) 1.64  0.13 M; siRNA-PTEN(219) 
1.74  0.14 M; n  18, p < 0.05). Taken together, these data show that downregulation of PTEN 
expression globally affects intracellular Ca
2+
 signalling acting on the ER Ca
2+
 release machinery. 
 
ER-localized PTEN, but not wild-type PTEN, enhances the agonist-dependent mitochondrial Ca
2+
 
response 
In order to test whether the effects of PTEN on regulation of Ca
2+
 homeostasis were specifically 
dependent on its localization in the ER and MAMs, we generated a chimeric protein, designated 
ER-PTEN, that targets the entire PTEN protein to the cytoplasmic surface of the ER membrane 
(Figure 22b). We verified the intracellular distributions of endogenous, recombinant and ER-
targeted PTEN in HEK-293 cells co-transfected with erGFP as a marker for the ER. 
Immunofluorescence analyses confirmed the presence of endogenous PTEN at the ER, where it 
slightly co-localize with erGFP (Figure 22a, A-A‟‟). When analyzing the transfected wild-type 
PTEN staining pattern, we found a higher overlap with the ER, but PTEN was also found diffusely 
accumulated in the nucleus (Figure 22a, B-B‟‟). Instead, ER-PTEN was predominantly localized in 
the ER and mostly excluded from the nucleus (Figure 22a, C-C‟‟). We also analysed recombinant 
PTEN and ER-PTEN chimera expression levels and effects on Akt phosphorylation (Figure 22c). 
We next determined whether overexpression of PTEN or ER-PTEN could differentially affect Ca
2+
 
handling of mitochondria, the main proximal target of Ca
2+
 signals arising from the ER. 
Surprisingly, ER-PTEN significantly enhanced mitochondrial Ca
2+
 uptake evoked by agonist 
stimulation, while wild-type PTEN was indistinguishable from controls (Figure 22d and e, [Ca
2+
]m: 
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pcDNA3, 3.17  0.19 M; PTEN, 3.37  0.22 M, n = 18, p  0.5; ER-PTEN 4.13  0.22 M, n = 
18, p < 0.01).  
 
 
 
Figure 22. PTEN and ER-PTEN differentially affect mitochondrial Ca
2+
 uptake. (a) Immunofluorescence to detect 
localization of PTEN and targeted ER-PTEN. HEK-293 cells transiently expressing empty vector (pcDNA3) (A), PTEN 
(B) or ER-PTEN (C), and co-transfected with erGFP (green images: A’-C’), were stained for PTEN (red images: A-C). 
Co-localisation of the green and red signals, yielding a yellow staining, is apparent in the merged images (merge: A’’- 
C’’). (b) Schematic map of the ER-PTEN chimera. (c) PTEN and ER-PTEN expression, and Akt phosphorylation were 
investigated by immunoblot of whole cell lysates using total and phospho-specific antibodies. Numbers indicate 
densitometrically determined protein levels relative to actin for PTEN and to total Akt for pAktSer473. (d) Bar graph of 
the average [Ca2+]m peak. (e) Mitochondrial Ca
2+ homeostasis modulation after ER-PTEN overexpression. Traces and 
bar graphs  are representatives of  18 samples from at least three independent experiments that yielded similar results. 
 
 
The same [Ca
2+
]m increase was observed also using a different ER-targeting PTEN chimera (Figure 
23). Collectively, these data indicate that a subpopulation of cellular PTEN localized at the ER is 
specifically involved in the regulation of the agonist-induced Ca
2+
 fluxes from the ER to 
mitochondria. 
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Figure 23 Effect of Cb5-PTEN chimera 
overexpression on mitochondrial Ca
2+
 
uptake (a) Representative traces of 
mitochondrial Ca2+ transients evoked by 
100 M ATP in Cb5-PTEN-
overexpressing HEK-293 cells. (b) 
Average [Ca2+]m peak (pcDNA3, 2.66  
0.16 M; ER-PTEN 3.71  0.22 M, n = 
20, p < 0.01). 
 
 
 
 
Ca
2+
 mobilization from intracellular stores evoked by arachidonic acid is impaired when PTEN is 
silenced and increased through targeting of PTEN to the ER 
The transfer of Ca
2+
 from the ER to mitochondria not only controls a variety of physiological 
processes during cell activation, but can also be a potent death-inducing signal (135). In order to test 
whether PTEN is involved in remodelling ER-mitochondrial Ca
2+
 flux also during apoptosis-
inducing Ca
2+
 signals, we investigated Ca
2+
 dynamics in response to the lipid mediator arachidonic 
acid (ArA) (269) after PTEN silencing, overexpression or targeting to the ER. ArA is proposed to 
initiate apoptotic death through a Ca
2+
-controlled process: it progressively releases Ca
2+
 from 
intracellular stores, thereby directly causing a long-lasting [Ca
2+
]c rise that finally leads to the 
mitochondrial permeability transition and release of caspase cofactor (143, 147). In our 
experiments, we measured the release of Ca
2+
 from intracellular stores by monitoring cytosolic Ca
2+
 
responses over time with the dye Fura-2/AM (270). In order to identify transfected cells in single 
cell imaging experiments, HEK-293 cells were co-transfected with mtRFP; untransfected cells in 
the same sample were used to compare changes in the 340/380 Fura-2/AM ratio. Treatment of 
untransfected or mock-transfected cells with 80 M ArA caused a cytosolic Ca2+ elevation that 
gradually increased over time. Consistent with the impaired release of ER Ca
2+
 in response to 
agonists coupled to IP3 mobilization, the increase in cytosolic Ca
2+
 induced by ArA was markedly 
blunted in PTEN-silenced cells (Figures 24a and b). The overexpression of PTEN did not cause any 
difference in the release of Ca
2+
 evoked by ArA, while ER-PTEN significantly increased the 
cytosolic Ca
2+
 responses (Figures 24c and d). Overall, these experiments indicate that the absence 
of PTEN causes a reduction in the cytosolic Ca
2+
 rise elicited by the discharge of intracellular Ca
2+
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stores after apoptotic stimuli. Moreover, we confirmed that ER-localized PTEN can enhance the 
Ca
2+
-dependent death signalling. 
 
 
 
Figure 24. Effect of PTEN silencing or overexpression on cytosolic Ca
2+
 responses after exposure to 80 M 
arachidonic acid. HEK-293 cells were co-transfected with mtRFP and the indicated plasmid in a 1:1 ratio in order to 
distinguish transfected cells (positive). Untransfected cells (negative) were used to compare changes in the 340/380 
Fura-2/AM ratio on the same sample as detailed in Materials and Methods. After loading with the Ca2+ indicator Fura-
2/AM, cells were maintained in 1 mM Ca2+/KRB and, where indicated, challenged with 80 M ArA. The kinetics of the 
cytosolic Ca2+ response (a and c) are presented as the ratio of fluorescence at 340 nm/380 nm. In the bar graphs (b and 
d) every F340/F380 value is normalized to the start value; the average of normalized (F340/F380) over time in all the 
single cell imaging experiments performed was then calculated. (a) Representative traces of cytosolic Ca2+ responses in 
PTEN-silenced cells. (b) Statistics analysis of cytosolic Ca2+ increase in PTEN-silenced cells. Normalized (F340/F380): 
pSUPER [negative 31.66  5.94 (n=20 cells); positive 28.77  4.43 (n=33 cells)]; siPTEN(1049) [negative 31.65  
4.60 (n=31 cells); positive 16.71  2.51 (n=39 cells), p  0.05 compared to pSUPER]; siPTEN(219) [negative 31.75  
4.17 (n=44 cells); positive 17.66  1.62 (n=55 cells), p  0.05 compared to pSUPER]. (c) Representative traces of 
cytosolic Ca2+ responses in cells overexpressing PTEN or targeted ER-PTEN chimera. (d) Statistics of cytosolic Ca2+ 
increase in PTEN or ER-PTEN overexpressing cells. Normalized (F340/F380): pcDNA3 [negative 124.75  8.50 (n=20 
cells); positive 107.03  8.56 (n=25 cells)]; PTEN [negative 123.13  12.16 (n=18 cells); positive 123.01  11.15 
(n=24 cells)]; ER-PTEN [negative 123.62  7.84 (n=26 cells); positive 141.14  9.44 (n=36 cells), p  0.01 compared 
to pcDNA3]. The traces and bar graphs are representative of at least three independent experiments that yielded 
similar results. 
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Ca
2+
-mediated apoptosis is prevented by PTEN silencing and enhanced through overexpression of 
ER-PTEN 
ER-to-mitochondria Ca
2+
 transfer has been implicated in multiple models of apoptosis as being 
directly responsible for mitochondrial Ca
2+
 overload (142, 189), which sensitizes the organelle to 
apoptotic challenges and may result in the induction of cell death through PTP opening, 
mitochondria swelling and release of caspase cofactors (222). Previous studies have established that 
the reduction in the Ca
2+
 amount that can be released from the ER and accumulated in mitochondria 
decreases the probability of Ca
2+
-dependent apoptosis (147, 194, 203, 206). Here, we tested whether 
PTEN, by affecting ER-mitochondria Ca
2+
 flux, could influence the apoptotic response to death 
stimuli that requires Ca
2+
 transfer between the two organelles. We used ArA since it triggers or 
enhances the release of Ca
2+
 from the ER and activates the intrinsic apoptotic pathway (143, 147, 
269). The effects on cell fate were evaluated by monitoring the processing of effector caspase-3 into 
active cleaved caspase-3 fragments.  
Immunoblot results showed that after ArA treatment a smaller amount of cleaved caspase-3 is 
present in PTEN-silenced cells than in control (mock-transfected) cells (Figures 25a and c). This 
indicates that the reduction of ER Ca
2+
 release observed in PTEN-silenced cells increases the 
threshold for Ca
2+
-mediated apoptosis. After ArA treatment, cells also displayed a downregulation 
of PTEN expression in comparison to vehicle-treated cells, probably because during apoptotic cell 
death PTEN is cleaved by active caspase-3 (271, 272). We found a greater downregulation of PTEN 
expression in PTEN-silenced cells than in control cells, most likely due to their preferential survival 
(Figure 25b). Overexpression of wild type PTEN was unable to sensitize HEK-293 cells to 
ArA-induced apoptosis; indeed, the levels of cleaved caspase-3 were comparable to those observed 
in control cells (Figures 25d and f). Moreover, the reduction in PTEN protein levels is comparable 
to that observed in control cells (Figure 25e). Conversely, in cells overexpressing ER-PTEN, the 
sensitivity to apoptosis after ArA treatment was enhanced as indicated by the increased levels of 
cleaved caspase-3. These cells also displayed a greater reduction of PTEN levels, most likely due to 
increased apoptosis (Figures 25d-f). 
In conclusion, ER-localized PTEN sensitizes cells to apoptotic death by stimuli that require Ca
2+
 
transfer from ER to mitochondria. 
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Figure 25. Effect of PTEN silencing or overexpression on sensitivity to Ca
2+
-dependent apoptosis. HEK-293 cells 
were transfected with PTEN siRNAs,mPTEN, ER-PTEN or the respective empty vector; 36 h after transfection the cells 
were treated with 80 M arachidonic acid (ArA) or vehicle (EtOH) for 90 min; cell lysates were then prepared and 
analyzed by immunoblotting. Membranes were probed with antibodies against PTEN, actin and caspase-3 proteins. 
Representative immunoblots (a and d) from three independent experiments are shown. Numbers indicate 
densitometrically determined protein levels relative to actin for PTEN and to caspase-3 (35 kDa) for cleaved caspase-3 
(17 kDa). The bar graphs show mean ± s.e.m. from densitometric analysis of normalized PTEN (b and e) and cleaved 
caspase-3 (c and f) protein levels. (a) PTEN silencing reduces caspase-3 activation after ArA challenge. (b) Reduction 
in PTEN expression compared to vehicle, in PTEN-silenced cells. % PTEN/Actin: pSUPER 31.2  2.1%; siRNA-
PTEN(1049) 87.0  10.3%; siRNA-PTEN(219) 62.4  20.9%. (c) Caspase-3 activation expressed as percentage of 
control (mock-transfected) cells, after PTEN silencing. Cleaved caspase-3/caspase-3 band intensity: siRNA-
PTEN(1049) 64.3  6.7%, siRNA-PTEN(219) 63.0  7.9%, vs control cells 100%. (d) ER-PTEN enhanced caspase-3 
activation after ArA challenge. (e) Reduction in PTEN expression compared to vehicle, in cells overexpressing PTEN or 
ER-PTEN. % PTEN/Actin: pcDNA3 24.1  2.8%; PTEN 28.0  1.4%; ER-PTEN 43.6  4.3%. (f) Caspase-3 
activation expressed as percentage of control (mock-transfected) cells, after overexpression of PTEN or ER-PTEN. 
Cleaved caspase-3/caspase-3 band intensity: PTEN 104.5  11.2%, ER-PTEN 152.3  24.3%, vs control cells 100%. 
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Discussion 
 
PTEN is a phosphatase whose main tumour suppressor activity is likely to be caused by 
dephosphorylation of the lipid second messenger PIP3, which accumulates at the plasma membrane 
upon activation of PI3K (273). Even though PTEN has multiple domains for membrane association, 
in most mammalian cell types it does not show an obvious association with the plasma membrane 
(274). Differing results show PTEN localization distributed between cytosol and nucleus and there 
is evidence that it could operate as a tumour suppressor in both these compartments (275). PTEN 
could also accumulate in mitochondria in cells undergoing apoptosis and is implicated in the 
regulation of the intrinsic apoptotic pathway (267, 268). These findings highlight the importance of 
PTEN‟s subcellular localization in regulating its function and point out the possibility that different 
tumour-suppressive mechanisms of action may occur in well-defined cellular compartments. 
In this part of the PhD project, we investigated in greater detail the intracellular distribution of 
PTEN using an established fractionation protocol (160). Our results showed that, in addition to 
cytosolic, nuclear and mitochondrial pools, PTEN is also present in the ER and MAMs. Since a 
major area of functional interaction between the ER and mitochondria is the control of Ca
2+
 
signalling, and growing evidence indicates that the Ca
2+
 uptake into mitochondria is controlled by 
specific proteins residing at the ER and MAMs (see Introduction, section 1.7), our finding raises the 
possibility that PTEN could act as a tumour suppressor, at least in part, by modulating the 
transmission of Ca
2+
 from the ER to mitochondria. We confirm this possibility by showing a 
reduction in the kinetics of Ca
2+
 release from the ER in PTEN-silenced cells, that significantly 
blunted also the cytosolic and the mitochondrial Ca
2+
 responses. Previous experiments ruled out the 
possibility that our results could be a consequence of decreased production of IP3 on phospholipase 
C activation (276, 277). To outline the functional relevance of PTEN localization in the ER and 
MAMs in modulating Ca
2+
 signalling, we generated an ER-targeted PTEN chimera and 
demonstrated that its transient overexpression significantly increased the agonist-induced 
mitochondrial Ca
2+
 transient, which is a proximal sensor of Ca
2+
 release through IP3Rs (30), while 
wild-type PTEN overexpression had no effect. We concluded that PTEN‟s regulation of Ca2+ 
homeostasis relied specifically on its localization in the ER and MAMs. 
Ca
2+
 signalling is an important regulator of both cell proliferation and apoptosis (5). Broad evidence 
has established that mitochondrial Ca
2+
 loading favours apoptosis; reducing or increasing the Ca
2+
 
amount that can be released from the ER to mitochondria protects from or enhances apoptosis, 
respectively (see Introduction, section 1.6). There is an increasing number of reports supporting the 
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role of Ca
2+
 signalling remodelling for cancer cell proliferation and survival (3). Our results confirm 
this possibility for PTEN, as decreased release of Ca
2+
 from the ER in PTEN-silenced cells accounts 
for reduced sensitivity to apoptosis. Moreover, we demonstrated that only ER-localized PTEN is 
able to increase ER Ca
2+
 release in response to ER death stimuli, in turn engaging mitochondria in a 
Ca
2+
-dependent apoptotic process. Therefore, PTEN in the ER and MAMs is critical for cell death 
regulation by this tumour suppressor, and loss of PTEN function could limit apoptosis-inducing 
Ca
2+
 signals during cancer. The tumour-suppressive function of PTEN at the ER and MAMs can 
also explain why the E307K mutation in MDA-MB-453 breast carcinoma cell line lead to higher 
PTEN plasma membrane localization which confers a greater ability in suppressing pAkt levels 
(278); it is possible that this mutation results in the inability of PTEN to be targeted to the ER and 
MAMs, and so limits Ca
2+
-dependent death signalling. 
At present, the precise molecular mechanism by which PTEN localizes to the ER and MAMs, and 
regulates ER-to-mitochondria Ca
2+
 transport remains unclear, but several possibilities exist (Figure 
26). The major site of PIP2 and PIP3 accumulation is the plasma membrane. Lindsay et al. 
estimated that intracellular membranes accounted for no more than 10-20% of total PIP3 and 
suggest that PTEN is only active as a lipid phosphatase when targeted to plasma membranes (279). 
However, both PIP2 (280, 281) and PIP3 (282) have been detected in intracellular organelles 
including the ER, and Sato emphasized how signalling pathways downstream of PIP3, including 
Akt, are activated at intracellular compartments remote from the plasma membrane. This could 
explain both recruitment and potential functional consequence of PTEN in the ER, since PTEN 
association with membranes depends on their composition, in particular on the presence of PIP2 
(283, 284). Since PTEN is known to be involved in forming gradients of PIP3 necessary for 
sustaining cell polarity during motility (285), our data suggests that it could function in a spatially 
restricted manner and regulate PIP2/PIP3 turnover for generating microdomains of activated Akt on 
the ER surface. In this way, PTEN may modulate Akt-dependent phosphorylation of IP3Rs, which 
reduced their Ca
2+
 release activity (66, 146, 147), through the efficient localization to specific ER 
and MAMs sites where its activity is needed. However, there are also other possibilities that we 
cannot exclude at present. PTEN also possesses multiple biological functions independent of its 
lipid phosphatase activity. It is likely that it exerts such functions by protein-protein interaction or 
by its protein phosphatase activity. A number of PTEN-interacting proteins are known (286), 
including PP2a (287), PML (241) and PP1 (288). All these proteins are also known interactors and 
functional modulators of IP3R phosphorylation and, in turn, regulate IP3R-mediated Ca
2+
 release 
from the ER (206, 289). Several possibilities exist regarding these PTEN-interacting proteins: (i) 
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they could associate with a subpopulation of PTEN to guide it to the ER and MAMs and thus to a 
specific target; (ii) they could regulate PTEN function, including its enzymatic activity, or 
conversely (iii) PTEN could regulate the function of this binding partners; (iv) moreover, since 
several substrates for PTEN‟s protein phosphatase activity have been proposed, it could also act in 
the ER and MAMs as a protein phosphatase on still unidentified substrates. Future experiments will 
be required to determine the precise molecular mechanism by which ER- and MAMs-localized 
PTEN controls Ca
2+
 flux from the ER to mitochondria. 
 
 
 
Figure 26. PTEN effects on Ca
2+
 homeostasis: schematic model of the possible molecular mechanisms.  
 
 
PTEN is a multifunctional protein that, in addition to its canonical PIP3 phosphatase-dependent 
functions, can exert multiple biological functions at the same time. Several findings suggest that the 
subcellular localization of PTEN may be a regulatory mechanism for separating certain specific 
functions simultaneously conducted in the same cells (263, 265). Overall, the data presented in this 
thesis reveal that a subpopulation of PTEN is localized at the ER-MAMs interface with 
mitochondria, where it regulates the ER-mitochondria interorganelle Ca
2+
 signalling and exerts a 
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pro-apoptotic activity. This novel function may integrate its previously reported roles in tumour 
suppression and serve as a novel strategy for targeted therapeutic intervention. 
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4.MATERIALS AND METHODS: 
 
 
 
Cells culture and Transfection  
HeLa and HEK-293 cells were grown in Dulbecco‟s modified Eagle‟s medium (DMEM) 
(Euroclone), supplemented with 10% fetal bovine serum (FBS). Primary MEFs were prepared from 
embryos at day 13.5 of development (E13.5). Early passage (P2–P5) MEFs were grown in DMEM 
supplemented with 10% FCS. HEK-293 cells were seeded 48 h before transfection onto glass 
coverslips coated with poly-L-lysine (Sigma), 13-mm in diameter for aequorin experiments, or 24-
mm for Fura-2/AM measurements and immunofluorescence. For immunoblot and cell death 
experiments, cells were seeded on 10-cm Petri dishes or 24-mm coverlip. 
HeLa and HEK-293 cells were allowed to grow to 50% confluence, transfected with a standard 
calcium-phosphate procedure and used in the experiments 36 h post-transfection. MEFs were 
transfected with different constructs using the MicroPorator (Digital Bio). 
 
Plasmid cloning 
For selective VDAC silencing several sequences were cloned and tested for specific silencing 
efficiency without upregulation of the other isoforms. The most effective sequences were: 50-
AAGCGGGAGCACATTAACCTG-30 for hVDAC1; 50-AAGGATGATCTCAACAAGAGC-30 
for hVDAC2; 50-AAGGGTGGCTTGCTGGCTATC-30 for hVDAC3. To silence PTEN specific 
siRNA were designed: siPTEN(1049): nucleotides 1049–1067 of the corresponding mRNA (5‟-
AGTAGAGGAGCCGTCAAAT-3‟); siPTEN(219): nucleotides 219–237 of the corresponding 
mRNA (5‟-AGACATTATGACACCGCCA-3‟). Oligonucleotides containing the selected 
sequences were purchased from Sigma-Aldrich and cloned into pSUPER (Oligoengine) according 
to the manufacturer‟s instructions.  
ErPML chimera was addressed to the external surface of ER by fusing sequence from the yeast 
UBC6  protein (245) to the C-terminal end of the human PML isoform IV. 
Human PTEN was cloned into pcDNA3 (Invitrogen) and PTEN chimeras were targeted to the 
external surface of the ER by fusing sequences from UBC6 (ER-PTEN) (245) or cytochrome b5 
(Cb5) (Cb5-PTEN) (290) to the N-terminus of PTEN. 
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Subcellular Fractionation 
Subcellular fractionation of cells and Percoll purification of MAMs were performed as described 
previously (160, 206). 
Briefly, cells (10
9
) were harvested, washed by centrifugation at 500 g for 5 min with PBS, 
resuspended in homogenization buffer (225 mM mannitol, 75 mM sucrose, 30 mM Tris-HCl pH 
7.4, 0.1 mM EGTA, and PMSF) and gently disrupted by dounce homogenisation. The homogenate 
was centrifuged twice at 600 g for 5min to remove nuclei and unbroken cells, and then the 
supernatant was centrifuged at 10,300 g for 10 min to pellet crude mitochondria. The resultant 
supernatant was centrifuged at 100,000 g for 90 min (70-Ti rotor, Beckman) at 4 °C to pellet the ER 
fraction. The crude mitochondrial fraction, resuspended in isolation buffer (250 mM mannitol, 5 
mM HEPES pH 7.4 and 0.5 mM EGTA ), was subjected to Percoll gradient centrifugation (Percoll 
medium: 225 mM mannitol, 25 mM HEPES pH 7.4, 1 mM EGTA and 30% vol/vol Percoll) in a 10-
ml polycarbonate ultracentrifuge tube. After centrifugation at 95,000 g for 30 min a dense band 
containing purified mitochondria was recovered approximately at the bottom of the gradient (and 
further processed as described in (160)), whereas MAMs was retrieved as a diffuse white band 
located above the mitochondria. MAMs were diluted in isolation buffer and centrifuged at 6,300 g 
for 10 min. To pellet the MAMs fraction the supernatant was centrifuged at 100,000 g for 90 min 
(70-Ti rotor, Beckman) at 4 °C. 
 
Co-immunoprecipitation 
Co-immunoprecipitations were carried out by using protein A- or protein G-coated sepharose beads 
(GE Healthcare) following manufacturer‟s instructions. Different protein extraction buffers were 
used in order to minimize non-specific binding while maximizing antigen extraction. IP3R3 and 
IP3R1 were extracted in a modified RIPA buffer (150mM NaCl, 1% NP-40, 0.05% SDS, Tris 50 
mM, pH=8) while HA and grp75 were purified in a NP-40 buffer (150mM NaCl, 1% NP-40, Tris 
50 mM, pH=8), all supplemented with proteases and phosphatases inhibitors (2 mM Na3VO4, 2 mM 
NaF, 1 mM PMSF and Protease Inhibitor Cocktail). Extracted proteins (700 g) were first 
precleared by incubating lysates with sepharose beads for 1 h at 4 °C and the supernatant (referred 
as Input) was incubated overnight with the antibody at 4 °C. Precipitation of the immune complexes 
was carried for 2 h at 4 °C and washed three times with the extraction buffer.  
Pml
+/+
 and Pml
-/-
 MEFs extracts were prepared using lysis buffer containing: 50 mM NaCl, 50 mM 
Tris-HCl pH 7.4, 0.1% NP-40 supplemented with 1 mM PMSF and proteases/phosphatases 
inhibitors. Protein extracts were pre-cleared with protein G/A beads (Pierce) than precipitated with 
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IP3R3, PML, Akt and PP2a antibodies overnight at 4°C. Protein G beads were added and rocked 5 
hours at 4°C. Afterwards, beads were washed with 50 mM NaCl, 50 mM Tris-HCl pH 7.4, 0.1% 
NP-40 4°C. 
Samples were proceed by SDS-PAGE and analyzed by standard mmunoblot technique. 
 
Immunoblot 
Total cell lysates were prepared in RIPA buffer (50 mM Tris-HCl pH 7.8, 150 mM NaCl, 1% 
IGEPAL CA-630, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM DTT) supplemented with 
proteases and phosphatases inhibitors (2 mM Na3VO4, 2 mM NaF, 1 mM PMSF and Protease 
Inhibitor Cocktail). Proteins (30 g) were quantified using the Bradford assay (Bio-Rad 
Laboratories), separated by SDS-PAGE and transferred to nitrocellulose membranes for standard 
western blotting. Antibodies were purchased from the following sources and used at the indicated 
dilutions: PTEN (1:1000), Akt (1:1000), pAkt
Ser473
 (1:500), Caspase-3 (1:250) and PARP (1:2000) 
from Cell Signaling; actin (1:5000), β–tubulin (1:3000) and HA (1:5000) from Sigma-Aldrich; 
IP3R3 (1:250) from BD Biosciences; FACL4 (1:250), HK-I (1:1000) and grp75 (1:10 000) from 
Santa Cruz; lamin B1 (1:1000), VDAC2 (1:1000), VDAC3 (1:1000) and IP3R1 (1:1000) from 
Abcam, VDAC1 (1:10 000) from Calbiochem, anti-hPML (1:1000), anti-PML (1:1000) from 
Chemicon. 
Densitometric analysis of protein levels were performed with ImageJ software . 
 
Immunofluorescence 
MEFs were fixed in 4% paraformaldehyde in PBS for 15 min, washed three times with PBS, 
permeabilized for 10 min with 0.1% Triton X-100 in PBS and blocked in PBS containing 1% BSA 
for 20 min. Cells were then incubated O/N at 4°C in a wet chamber with the following antibodies: 
anti-PML (H-238, Santa Cruz) for erPML, or with the anti-PML (for endogenous PML), anti-
FACL, anti-PP2a, dilute 1:100 with 2% BSA in PBS. Staining was then carried out with Alexa 488 
anti-rabbit for hPML (erPML), with Alexa 488 anti-mouse for Pml, with Alexa 543 anti-rabbit for 
PP2a and with Alexa 633 anti-goat for FACL secondary antibodies.  
HEK-293 cells were grown on 24-mm coverslips and co-transfected with 4 μg of the indicated 
plasmids and 4 μg of erGFP. After 36 h, cells were fixed, washed, permeabilized and blocked in 
PBS containing 1% BSA for 20 min (as described above). Cells were then incubated O/N at 4°C 
with the PTEN antibody (1:100), and subsequent staining was carried out with AlexaFluor-
conjugated 546 (Invitrogen). 
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After each antibody incubation, cells were washed three times with 0.1% Triton X-100 in PBS. 
Samples were mounted in ProLong Gold antifade (Invitrogen) and images were obtained by high-
speed confocal fluorescence microscopy (Nikon LiveScan Swept Field Confocal Microscope). 
 
Immunoelectron microscopy 
MEF cells are fixed with 2% paraformaldehyde and 0.2% glutaraldehyde in PBS, embedded in 12% 
gelatin, 2,3 M sucrose and frozen in liquid nitrogen. Ultrathin cryosections, obtained by a Reichert-
Jung Ultracut E with FC4E cryoattachment, were collected on copper-formvar-carbon-coated grids. 
Immunogold localization was revealed using the PML Chemicon antibody for endogenous mouse 
PML and PML (H-238) Santa Cruz for erPML chimera, and 10 nm proteinA-gold conjugated, 
according published protocols (291, 292). All samples were examined in a Philips CM10 or a FEI 
Tecnai 12G2 electron microscopes. 
 
Aequorin measurements 
Cells grown on 13-mm round glass coverslips were co-transfected with 1 μg of aequorin 
(erAEQmut, cytAEQ, or mtAEQ) and 3 μg of the indicated siRNA or plasmid. After 36 h, cells 
were reconstituted and placed in a perfused thermostated chamber where the light signal was 
collected in a purpose-built luminometer and calibrated into [Ca
2+
] values as previously described 
(244). For [Ca
2+
]er measurements in HeLa and MEF cells, erAEQmut-transfected cells were 
reconstituted with coelenterazine n, following ER Ca
2+
 depletion in a solution containing 0 [Ca
2+
], 
500 M EGTA, 1 M ionomycin, as previously described. After three washes with KRB 
supplemented with 2% BSA and 1 mM EGTA, cells were perfused with Krebs-Ringer buffer 
(KRB: 135 mM NaCl, 5 mM KCl, 1 mM MgSO4, 0.4 mM KH2PO4, 5.5 mM glucose, 20 mM 
HEPES, pH 7.4) containing 100 M EGTA. HEK-293 cells transfected with erAEQmut were 
reconstituted with coelenterazine n (Tebu-Bio), after ER Ca
2+
 depletion by incubating cells for 1 h 
at 4°C in KRB supplemented with 100 M EGTA, and 40 M tBHQ (2,5-Di-tert-
butylhydroquinone) (Sigma); cells were then washed with KRB supplemented with 2% BSA and 1 
mM EGTA. ER refilling was then triggered by perfusing KRB buffer supplemented with 1mM 
CaCl2 until equilibrium (steady state) was reached. Cells transfected with cytAEQ and mtAEQ were 
reconstituted with coelenterazine (Synchem) for 2 h in KRB supplemented with 1 mM CaCl2. All 
aequorin measurements were carried out in 1 mM Ca
2+/KRB (cytAEQ and mtAEQ) or 100 μM 
EGTA/KRB (erAEQmut). Agonist was added to the same medium, as specified in the figures. The 
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experiments were concluded by lysing the cells with 100 M digitonin in a hypotonic Ca2+-rich 
solution (10 mM CaCl2 in H2O).  
 
Fura-2/AM measurements 
Cytosolic Ca
2+
 response was evaluated using the fluorescent Ca
2+
 indicator Fura-2/AM (Invitrogen). 
Cells were grown on 24-mm coverslips and co-transfected with 4 μg of the indicated siRNA or 
plasmid and 4 μg of mtRFP. After 36 h, cells were incubated at 37°C for 30 min in 1 mM 
Ca
2+
/KRB supplemented with 2.5 M Fura-2/AM, 0.02% Pluronic F-68 (Sigma), 0.1 mM 
Sulfinpyrazone (Sigma). Cells were then washed and supplied with 1 mM Ca
2+
/KRB. To determine 
cytosolic Ca
2+
 response cells were placed in an open Leyden chamber on a 37°C thermostatted 
stage and exposed to 340/380 wavelength light using the Olympus xcellence multiple wavelength 
high-resolution fluorescence microscopy system. The fluorescence data collected were expressed as 
emission ratios. 
 
Induction of Apoptosis 
HeLa cells grown on 24-mm coverlip at 30% confluence were co-transfected with GFP and control 
or siRNA-hVDACs containing plasmids in a 1:1 ratio. The effect on cell fate was evaluated by 
applying an apoptotic challenge (20 M C2-ceramide or 100 M H2O2) and comparing the survival 
of transfected and non-transfected cells. In these experiments, the percentage of GFP-positive cells 
was calculated before and after applying an apoptotic stimulus (C2-ceramide or H2O2). In mock-
transfected cells, although the total number of cells is reduced after cell death induction, the 
apparent transfection efficiency was maintained (i.e., transfected and nontransfected cells have the 
same sensitivity to the apoptotic stimulus and thus die to the same extent). However, when cells are 
transfected with a construct influencing their sensitivity to apoptosis, this will be reflected by a 
change in the fraction of fluorescent cells, that is, in the „apparent‟ transfection efficiency. Thus, 
protection from apoptosis results into an apparent increase of transfection, whereas a decrease 
reflects a higher sensitivity to apoptosis. Data are reported as the mean percentage change in the 
apparent transfection efficiency after apoptotic challenge compared with vehicle-treated cells. Cells 
were extensively washed with PBS, stained with DAPI, and two images per field (blue and green 
fluorescence) were taken at  10 magnification (mean transfection efficiency were roughly 30% for 
all conditions). At least 10 fields per coverslip were randomly imaged and counted. Data presented 
are the sum of at least two different wells per experimental condition carried out in three different 
independent experiments. 
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MEFs Pml
+/+
 and Pml
-/-
 apoptosis was determined by FACS analysis of cells stained with Annexin-
V FITC/Propidium Iodide (BioVision). For cell death induction cells were treated as indicated in 
the text with 1 mM H2O2, 15 M MEN, 6 M TN, 2 M TG and 50 M ETO in DMEM, 
supplemented with 10% FCS. 
HEK-293 cells were grown on 10-cm Petri dishes and transfected with the indicated siRNA, 
plasmid or empty vector. After 36 h, cells were washed and growth media was replaced with 1 mM 
Ca
2+
/KRB containing 80 M arachidonic acid (ArA) (Santa Cruz) for 90 min. Cells in the media 
were retained and pooled with remaining adherent cells that were harvested by scraping, collected 
by centrifugation at 200 g for 5 min and lysed as described above. 
 
Statistical analyses 
Statistical analyses were performed using Student‟s t-test. A p-value ≤ 0.05 was considered 
significant. All data are reported as mean ± s.e.m., or means  SD where indicated. 
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